Literature for peptidase C01.034: cathepsin S

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, A Assay, T Target, P Specificity, K Knockout, E Expression, V Review, M Mutation, I Inhibitor, L Localization, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

2025

Adhikari,R.P. and Ghosh,N.S. Exploring the role of Cathepsin S in mitochondrial energy metabolism: implications for cancer progression and therapeutic targeting Med Oncol (2025) 42, 505-505. PubMed Europe PubMed DOI
Bentley,D., Mannino,M., Manchester,M., Teixeira,P.C., Reis,B., Boyce,M. and Nagel,S. A randomized, double-blind, placebo-controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease Clin Transl Sci (2025) 18, e13901-e13901. PubMed Europe PubMed DOI PMC EPMC I
Chang,Y.C., Chen,S.J., Chen,S.H., Hsiao,S.Y., Chen,L.H., Chen,C.H., Liu,C.C., Chen,Y.W., Liu,K.J., Wu,S.Y., Chu,J.M., Qiu,L.Y., Chiang,W.F., Hsieh,H.P., Hsueh,W.Y., Hsiao,J.R., Shen,M.R., Chang,J.Y. and Chang,K.Y. Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer J Biomed Sci (2025) 32, 69-69. PubMed Europe PubMed DOI PMC EPMC
DeHority,R., Gil Pineda,L.I., Cochran,K., Chen,B., Bratek,D., Helm,R.F., Lemkul,J.A. and Zhang,C. The pH-Dependent Specificity of Cathepsin S and Its Implications for Inflammatory Communications and Disease Biochemistry (2025) PubMed Europe PubMed DOI
Deng,B., Liao,Z., Huang,L., Chen,T., Chen,Q., Zhong,S. and Huang,Z. Mendelian randomization and AlphaFold3 analysis suggest putative causal plasma proteins in graves' disease J Bioinform Comput Biol (2025) 23, 2550023-2550023. PubMed Europe PubMed DOI
Gao,H., Zhang,Z., Deng,J. and Song,Y. Cathepsin S: molecular mechanisms in inflammatory and immunological processes Front Immunol (2025) 16, 1600206-1600206. PubMed Europe PubMed DOI PMC EPMC
Geetha,D., Hameeda,B.A.A., Jose,D., Kuriakose,N. and Skaria,T. Novel Insights Into the Dynamic Conformational Transitions and Active Site Plasticity of Human Immunoregulatory Cathepsin S Proteins (2025) PubMed Europe PubMed DOI
Lin,Z. and Ruan,H.B. Cutting the Gordian knot: Untangling gasdermin C from pyroptosis Immunity (2025) 58, 2359-2361. PubMed Europe PubMed DOI
Ma,T., Yang,C., Wang,Y., Tu,C., Zhang,J., Mai,K., Wu,S., Zhou,H., Li,S., Ye,S., Liang,L., Huang,Q., Zhang,Z., Lin,Z., Pan,W. and Yang,Z. Cathepsin S contributes to influenza-induced lung injury by driving inflammation, promoting apoptosis, and disrupting epithelial barrier integrity Microbiol Spectr (2025) , e0112825-e0112825. PubMed Europe PubMed DOI
O'Hare,S., Tolmachova,K.A. and Bode,J.W. Chemoselective Installation of Electrophilic Warheads onto C-Terminal Peptide Hydrazides for Covalent Protease Inhibitor Synthesis ACS Chem Biol (2025) PubMed Europe PubMed DOI
Previti,S., Iraci,N., Calcaterra,E., Ettari,R. and Zappala,M. A Second Opportunity for the Peptide-Based Analogues with gamma-Lactam at the P1 Position: Human Cathepsin S Inhibition Pharmaceuticals (Basel) (2025) 18 PubMed Europe PubMed DOI PMC EPMC I
Xu,R.C., Sun,J.L., Wang,F., Liu,H.H., Qi,Z.R., Shi,X., Yu,X.N., Liu,T.T., Weng,S.Q., Dong,L., Shen,X.Z. and Zhu,J.M. Cathepsin S regulates ferroptosis sensitivity in hepatocellular carcinoma through the KEAP1-NRF2 signaling pathway Redox Biol (2025) 86, 103815-103815. PubMed Europe PubMed DOI PMC EPMC
Yang,C., Fu,L., Li,R., Tang,H., Chen,Z., Gan,S., Sun,J., Li,S., Li,J. and Yao,L. Cathepsin S mediates the disruption of airway epithelial Pannexin 1 via an Akt-dependent pathway in an LPS-induced murine model of acute lung injury Exp Cell Res (2025) 450, 114663-114663. PubMed Europe PubMed DOI I

2024

Deng,T., Lu,X., Jia,X., Du,J., Wang,L., Cao,B., Yang,M., Yin,Y. and Liu,F. Cathepsins and cancer risk: a Mendelian randomization study Front Endocrinol (Lausanne) (2024) 15, 1428433-1428433. PubMed Europe PubMed DOI PMC EPMC
Domain,R., Seren,S., Jerke,U., Makridakis,M., Chen,K.J., Zoidakis,J., Rhimi,M., Zhang,X., Bonvent,T., Croix,C., Gonzalez,L., Li,D., Basso,J., Paget,C., Viaud-Massuard,M.C., Lalmanach,G., Shi,G.P., Aghdassi,A., Vlahou,A., McDonald,P.P., Couillin,I., Williams,R., Kettritz,R. and Korkmaz,B. Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases) Biochem Pharmacol (2024) 229, 116114-116114. PubMed Europe PubMed DOI
Estur,F., Murigneux,E., David,A., Magnen,M., Saidi,A., Lalmanach,G. and Lecaille,F. Short-term exposure to cigarette smoke upregulates cathepsin S and alters expression of tight junction ZO-1 Biochimie (2024) 226, 34- PubMed Europe PubMed DOI
Gallwitz,L., Bleibaum,F., Voss,M., Schweizer,M., Spengler,K., Winter,D., Zophel,F., Muller,S., Lichtenthaler,S., Damme,M. and Saftig,P. Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis Cell Mol Life Sci (2024) 81, 227-227. PubMed Europe PubMed DOI PMC EPMC
Meta,M., Zimmer,C., Fuchs,N., Zecher,M.J., Lahu,A. and Schirmeister,T. Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability ACS Med Chem Lett (2024) 15, 837-844. PubMed Europe PubMed DOI PMC EPMC
Xu,B., Mountford,S.J., Thompson,P.E. and Edgington-Mitchell,L.E. Expanding the Library of Covalent Cysteine Cathepsin Probes Featuring Sulfoxonium Ylide Electrophiles ACS Omega (2024) 9, 43940-43947. PubMed Europe PubMed DOI PMC EPMC
Yu,P.W., Kao,G., Dai,Z., Nasertorabi,F. and Zhang,Y. Rational design of humanized antibody inhibitors for cathepsin S Arch Biochem Biophys (2024) 751, 109849-109849. PubMed Europe PubMed DOI PMC EPMC
Zhang,Y., Yang,L., Gan,Y., Zhao,C., Zhou,C., Chen,J., Yin,Y., Xia,S., Yang,H., Bao,X., Zhang,M., Xu,Y. and Li,J. Benzydamine attenuates microglia-mediated neuroinflammation and ischemic brain injury by targeting cathepsin s Int Immunopharmacol (2024) 146, 113824-113824. PubMed Europe PubMed DOI I

2023

Abdoli,M., Krasniqi,V., Bonardi,A., Gutschow,M., Supuran,C.T. and Zalubovskis,R. 4-Cyanamido-substituted benzenesulfonamides act as dual carbonic anhydrase and cathepsin inhibitors Bioorg Chem (2023) 139, 106725-106725. PubMed Europe PubMed DOI I
Fuchs,N., Meta,M., Lantzberg,B., Bros,M., Ling Kuan,S., Weil,T. and Schirmeister,T. Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible alpha-Fluorovinylsulfones and alpha-Sulfonates as Potential Immunomodulators in Cancer ChemMedChem (2023) 18, e202300160-e202300160. PubMed Europe PubMed DOI I
Huang,H., Zhang,Y., Xu,X., Liu,Y., Zhao,J., Ma,L., Lei,J., Ge,W., Li,N., Ma,E., Li,Y. and Yuan,L. Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells Bioorg Med Chem Lett (2023) 80, 129087-129087. PubMed Europe PubMed DOI I
Kotsiliti,E. Cathepsin S in liver fibrogenesis Nat Rev Gastroenterol Hepatol (2023) 20, 631-631. PubMed Europe PubMed DOI
Quinn,J.P., Ethier,E.C., Novielli,A., Malone,A., Ramirez,C.E., Salloum,L., Trombetta,B.A., Kivisakk,P., Bremang,M., Selzer,S., Fournier,M., Das,S., Xing,Y., Arnold,S.E. and Carlyle,B.C. Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer's Disease J Am Soc Mass Spectrom (2023) 34, 649-667. PubMed Europe PubMed DOI PMC EPMC
Tusar,L., Loboda,J., Impens,F., Sosnowski,P., Van Quickelberghe,E., Vidmar,R., Demol,H., Sedeyn,K., Saelens,X., Vizovisek,M., Mihelic,M., Fonovic,M., Horvat,J., Kosec,G., Turk,B., Gevaert,K. and Turk,D. Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins Commun Biol (2023) 6, 450-450. PubMed Europe PubMed DOI PMC EPMC
Zuo,T., Xie,Q., Liu,J., Yang,J., Shi,J., Kong,D., Wang,Y., Zhang,Z., Gao,H., Zeng,D.B., Wang,X., Tao,P., Wei,W., Wang,J., Li,Y., Long,Q., Li,C., Chang,L., Ning,H., Li,Y., Cui,C., Ge,X., Wu,J., Li,G., Hong,X., Yang,X., Dai,E., He,F., Wu,J., Ruan,Y., Lu,S. and Xu,P. Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis Gastroenterology (2023) 165, 746-761. PubMed Europe PubMed DOI

2022

Bigot,P., Chesseron,S., Saidi,A., Sizaret,D., Parent,C., Petit-Court, Courty,Y., Lecaille,F. and Lalmanach,G. Cleavage of Occludin by Cigarette Smoke-Elicited Cathepsin S Increases Permeability of Lung Epithelial Cells Antioxidants (Basel) (2022) 12 PubMed Europe PubMed DOI PMC EPMC
Novinec,M., Bembic,P., Jankovic,M., Kisilak,M., Kljun,J. and Turel,I. Kinetic Characterization of Cerium and Gallium Ions as Inhibitors of Cysteine Cathepsins L, K, and S Int J Mol Sci (2022) 23 PubMed Europe PubMed DOI PMC EPMC
Sullivan,G.P., Davidovich,P., Munoz-Wolf,N., Ward,R.W., Hernandez Santana,Y.E., Clancy,D.M., Gorman,A., Najda,Z., Turk,B., Walsh,P.T., Lavelle,E.C. and Martin,S.J. Myeloid cell-derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement Sci Immunol (2022) 7, eade5728-eade5728. PubMed Europe PubMed DOI
Zhang,Q., Lu,X., Gao,L., Tao,S., Ge,Y., Cui,D., Zhu,R., Lu,W., Wang,J. and Jiang,S. In Vitro and In Vivo Antigen Presentation and Diagnosis Development of Recombinant Overlapping Peptides Corresponding to Mtb ESAT-6/CFP-10 Front Immunol (2022) 13, 872676-872676. PubMed Europe PubMed DOI PMC EPMC

2021

Bollavaram,K., Leeman,T.H., Lee,M.W., Kulkarni,A., Upshaw,S.G., Yang,J., Song,H. and Platt,M.O. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V Protein Sci (2021) PubMed Europe PubMed DOI
Falkowski,P., Mrozek,P., Lukaszewski,Z., Oldak,L. and Gorodkiewicz,E. An Immunosensor for the Determination of Cathepsin S in Blood Plasma by Array SPRi-A Comparison of Analytical Properties of Silver-Gold and Pure Gold Chips Biosensors (Basel) (2021) 11 PubMed Europe PubMed DOI PMC EPMC
Fu,R., Edman,M.C. and Hamm-Alvarez,S.F. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells Int J Mol Sci (2021) 22 PubMed Europe PubMed DOI PMC EPMC
Gorican,T., Ciber,L., Petek,N., Svete,J. and Novinec,M. Synthesis and kinetic characterization of hyperbolic inhibitors of human cathepsins K and S based on a succinimide scaffold Bioorg Chem (2021) 115, 105213-105213. PubMed Europe PubMed DOI
Oldak,L., Sankiewicz,A., Zelazowska-Rutkowska,B., Cylwik,B., Lukaszewski,Z., Skoczylas,M. and Gorodkiewicz,E. Two SPRi biosensors for the determination of cathepsin S in blood plasma Talanta (2021) 225, 121900-121900. PubMed Europe PubMed DOI I
Soond,S.M., Savvateeva,L.V., Makarov,V.A., Gorokhovets,N.V., Townsend,P.A. and Zamyatnin,A.A., Jr. Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis Pharmaceutics (2021) 13 PubMed Europe PubMed DOI PMC EPMC
Wei,L., Shao,N., Peng,Y. and Zhou,P. Inhibition of Cathepsin S Restores TGF-beta-induced Epithelial-to-mesenchymal Transition and Tight Junction Turnover in Glioblastoma Cells J Cancer (2021) 12, 1592-1603. PubMed Europe PubMed DOI PMC EPMC
Zhao,J., Yang,Y. and Wu,Y. The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy Front Pediatr (2021) 9, 631473-631473. PubMed Europe PubMed DOI PMC EPMC

2020

Cathepsin S protease mediates T-cell response in non-Hodgkin lymphoma Cancer Discov (2020) 10, 761-761. PubMed Europe PubMed DOI
Ahmad,S., Bhagwati,S., Kumar,S., Banerjee,D. and Siddiqi,M.I. Molecular modeling assisted identification and biological evaluation of potent cathepsin S inhibitors J Mol Graph Model (2020) 96, 107512-107512. PubMed Europe PubMed DOI I
Andrault,P.M., Panwar,P. and Bromme,D. Characterization of cathepsin S exosites that govern its elastolytic activity Biochem J (2020) 477, 227-242. PubMed Europe PubMed DOI
Brown,R., Nath,S., Lora,A., Samaha,G., Elgamal,Z., Kaiser,R., Taggart,C., Weldon,S. and Geraghty,P. Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics Respir Res (2020) 21, 111-111. PubMed Europe PubMed DOI PMC EPMC
Chang,Z., Zhao,G., Zhao,Y., Lu,H., Xiong,W., Liang,W., Sun,J., Wang,H., Zhu,T., Rom,O., Guo,Y., Fan,Y., Chang,L., Yang,B., Garcia-Barrio,M.T., Lin,J.D., Chen,Y.E. and Zhang,J. BAF60a Deficiency in Vascular Smooth Muscle Cells Prevents Abdominal Aortic Aneurysm by Reducing Inflammation and ECM (Extracellular Matrix) Degradation Arterioscler Thromb Vasc Biol (2020) , ATVBAHA120314955-ATVBAHA120314955. PubMed Europe PubMed DOI K
Cianni,L., Rocho,F.D.R., Rosini,F., Bonatto,V., Ribeiro,J.F.R., Lameira,J., Leitao,A., Shamim,A. and Montanari,C.A. Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases Bioorg Chem (2020) 101, 104039-104039. PubMed Europe PubMed DOI I
da Costa,A.C., Santa-Cruz,F., Mattos,L.A.R., Rego Aquino,M.A., Martins,C.R., Bandeira Ferraz,A.A. and Figueiredo,J.L. Cathepsin S as a target in gastric cancer Mol Clin Oncol (2020) 12, 99-103. PubMed Europe PubMed DOI PMC EPMC V
Dheilly,E., Battistello,E., Katanayeva,N., Sungalee,S., Michaux,J., Duns,G., Wehrle,S., Sordet-Dessimoz,J., Mina,M., Racle,J., Farinha,P., Coukos,G., Gfeller,D., Mottok,A., Kridel,R., Correia,B.E., Steidl,C., Bassani-Sternberg,M., Ciriello,G., Zoete,V. and Oricchio,E. Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma Cancer Cell (2020) 37, 674-689. PubMed Europe PubMed DOI
Eckert WA 3rd, Wiener,J.J.M., Cai,H., Ameriks,M.K., Zhu,J., Ngo,K., Nguyen,S., Fung-Leung,W.P., Thurmond,R.L., Grice,C., Edwards,J.P., Chaplan,S.R., Karlsson,L. and Sun,S. Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouse Eur J Pharmacol (2020) , 173171-173171. PubMed Europe PubMed DOI K
Fei,M., Zhang,L., Wang,H., Zhu,Y., Niu,W., Tang,T. and Han,Y. Inhibition of Cathepsin S Induces Mitochondrial Apoptosis in Glioblastoma Cell Lines Through Mitochondrial Stress and Autophagosome Accumulation Front Oncol (2020) 10, 516746-516746. PubMed Europe PubMed DOI PMC EPMC
Flynn,C.M., Garbers,Y., Dusterhoft,S., Wichert,R., Lokau,J., Lehmann,C.H.K., Dudziak,D., Schroder,B., Becker-Pauly,C., Rose-John,S., Aparicio-Siegmund,S. and Garbers,C. Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro Sci Rep (2020) 10, 21612-21612. PubMed Europe PubMed DOI PMC EPMC
Fu,Q., Zhao,S., Yang,N., Tian,M., Cai,X., Zhang,L., Hu,J., Cao,M., Xue,T. and Li,C. Genome-wide identification, expression signature and immune functional analysis of two cathepsin S (CTSS) genes in turbot (Scophthalmus maximus L.) Fish Shellfish Immunol (2020) 102, 243-256. PubMed Europe PubMed DOI
Karimkhanloo,H., Keenan,S.N., Sun,E.W., Wattchow,D.A., Keating,D.J., Montgomery,M.K. and Watt,M.J. Circulating cathepsin S improves glycemic control in mice J Endocrinol (2020) PubMed Europe PubMed DOI
Lai,C.H., Chang,J.Y., Wang,K.C., Lee,F.T., Wu,H.L. and Cheng,T.L. Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice Eur J Vasc Endovasc Surg (2020) PubMed Europe PubMed DOI U I
Lemke,C., Cianni,L., Feldmann,C., Gilberg,E., Yin,J., Dos Reis Rocho,F., De Vita,D., Bartz,U., Bajorath,J., Montanari,C.A. and Gutschow,M. N-Sulfonyl dipeptide nitriles as inhibitors of human cathepsin S: In silico design, synthesis and biochemical characterization Bioorg Med Chem Lett (2020) 30, 127420-127420. PubMed Europe PubMed DOI I
Lyu,W., Jia,B., Liu,W. and Guo,Q. [Cathepsin S (CTSS) is highly expressed in temozolomide-resistant glioblastoma T98G cells and associated with poor prognosis] Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2020) 36, 924-929. PubMed Europe PubMed
McDowell,S.H., Gallaher,S.A., Burden,R.E. and Scott,C.J. Leading the invasion: The role of Cathepsin S in the tumour microenvironment Biochim Biophys Acta Mol Cell Res (2020) 1867, 118781-118781. PubMed Europe PubMed DOI
Michiels,T.J.M., Meiring,H.D., Jiskoot,W., Kersten,G.F.A. and Metz,B. Formaldehyde treatment of proteins enhances proteolytic degradation by the endo-lysosomal protease cathepsin S Sci Rep (2020) 10, 11535-11535. PubMed Europe PubMed DOI PMC EPMC
Montague-Cardoso,K. and Malcangio,M. Cathepsin S as a potential therapeutic target for chronic pain Med Drug Discov (2020) 7, 100047-100047. PubMed Europe PubMed DOI PMC EPMC
Moore,R.M., Katri,R., Kumar,D., Mansour,J.M., Mercer,B. and Moore,J.J. alpha-Lipoic acid blocks the GMCSF induced protease/protease inhibitor spectrum associated with fetal membrane weakening in-vitro Placenta (2020) 97, 79-88. PubMed Europe PubMed DOI
Ni,H., Xu,S., Chen,H. and Dai,Q. Nicotine Modulates CTSS (Cathepsin S) Synthesis and Secretion Through Regulating the Autophagy-Lysosomal Machinery in Atherosclerosis Arterioscler Thromb Vasc Biol (2020) , ATVBAHA120314053-ATVBAHA120314053. PubMed Europe PubMed DOI
Pantazopoulos,H., Gisabella,B., Rexrode,L., Benefield,D., Yildiz,E., Seltzer,P., Valeri,J., Chelini,G., Reich,A., Ardelt,M. and Berretta,S. Circadian Rhythms of Perineuronal Net Composition eNeuro (2020) 7 PubMed Europe PubMed DOI PMC EPMC
Peng,K., Liu,H., Yan,B., Meng,X.W., Song,S.Y., Ji,F.H. and Xia,Z. Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis J Cell Physiol (2020) PubMed Europe PubMed DOI
Pierre,O., Fouchard,M., Buscaglia,P., Le Goux,N., Leschiera,R., Mignen,O., Fluhr,J.W., Misery,L. and Le Garrec,R. Calcium Increase and Substance P Release Induced by the Neurotoxin Brevetoxin-1 in Sensory Neurons: Involvement of PAR2 Activation through Both Cathepsin S and Canonical Signaling Cells (2020) 9 PubMed Europe PubMed DOI PMC EPMC
Schade,M., Merla,B., Lesch,B., Wagener,M., Timmermanns,S., Pletinckx,K. and Hertrampf,T. Highly Selective Sub-Nanomolar Cathepsin S Inhibitors by Merging Fragment Binders with Nitrile Inhibitors J Med Chem (2020) 63, 11801-11808. PubMed Europe PubMed DOI
Smith,D., Cwiklinski,K., Jewhurst,H., Tikhonova,I.G. and Dalton,J.P. An atypical and functionally diverse family of Kunitz-type cysteine/serine proteinase inhibitors secreted by the helminth parasite Fasciola hepatica Sci Rep (2020) 10, 20657-20657. PubMed Europe PubMed DOI PMC EPMC
van Dalen,F.J., Bakkum,T., Van Leeuwen,T., Groenewold,M., Deu,E., Koster,A.J., van Kasteren,S.I. and Verdoes,M. Application of a Highly Selective Cathepsin S Two-step Activity-Based Probe in Multicolor Bio-Orthogonal Correlative Light-Electron Microscopy Front Chem (2020) 8, 628433-628433. PubMed Europe PubMed DOI PMC EPMC I
Wang,H., Wang,Z., Wang,L., Sun,L., Liu,W., Li,Q. and Wang,J. IL-6 promotes collagen-induced arthritis by activating the NLRP3 inflammasome through the cathepsin B/S100A9-mediated pathway Int Immunopharmacol (2020) 88, 106985-106985. PubMed Europe PubMed DOI
Wartenberg,M., Andrault,P.M., Saidi,A., Bigot,P., Nadal-Desbarats,L., Lecaille,F. and Lalmanach,G. Oxidation of cathepsin S by major chemicals of cigarette smoke Free Radic Biol Med (2020) 150, 53-65. PubMed Europe PubMed DOI
Wen,W., Sun,H., Yang,Y., Jia,Y., Fang,F., Qin,Y., Zhang,M. and Wei,Y. Usefulness of Cathepsin S to Predict Risk for Obstructive Sleep Apnea among Patients with Type 2 Diabetes Dis Markers (2020) 2020, 8819134-8819134. PubMed Europe PubMed DOI PMC EPMC

2019

Baranov,M.V., Bianchi,F., Schirmacher,A., van Aart,M.A.C., Maassen,S., Muntjewerff,E.M., Dingjan,I., Ter Beest,M., Verdoes,M., Keyser,S.G.L., Bertozzi,C.R., Diederichsen,U. and van den Bogaart,G. The phosphoinositide kinase PIKfyve promotes cathepsin-S-mediated major histocompatibility complex class II antigen presentation iScience (2019) 11, 160-177. PubMed Europe PubMed DOI PMC EPMC
Chang,C.J., Hsu,H.C., Ho,W.J., Chang,G.J., Pang,J.S., Chen,W.J., Huang,C.C. and Lai,Y.J. Cathepsin S promotes the development of pulmonary arterial hypertension Am J Physiol Lung Cell Mol Physiol (2019) 317, L1-L1. PubMed Europe PubMed DOI
Chaput,L., Selwa,E., Elisee,E. and Iorga,B.I. Blinded evaluation of cathepsin S inhibitors from the D3RGC3 dataset using molecular docking and free energy calculations J Comput Aided Mol Des (2019) 33, 93-103. PubMed Europe PubMed DOI I
Chung,K., Pitcher,T., Grant,A.D., Hewitt,E., Lindstrom,E. and Malcangio,M. Cathepsin S acts via protease-activated receptor 2 to activate sensory neurons and induce itch-like behaviour Neurobiol Pain (2019) 6, 100032-100032. PubMed Europe PubMed DOI PMC EPMC
Doherty,D.F., Nath,S., Poon,J., Foronjy,R.F., Ohlmeyer,M., Dabo,A.J., Salathe,M., Birrell,M., Belvisi,M., Baumlin,N., Kim,M.D., Weldon,S., Taggart,C. and Geraghty,P. Protein phosphatase 2A reduces cigarette smoke-induced cathepsin S and loss of lung function Am J Respir Crit Care Med (2019) 200, 51-62. PubMed Europe PubMed DOI K
He,X., Man,V.H., Ji,B., Xie,X.Q. and Wang,J. Calculate protein-ligand binding affinities with the extended linear interaction energy method: application on the cathepsin S set in the D3R Grand Challenge 3 J Comput Aided Mol Des (2019) 33, 105-117. PubMed Europe PubMed DOI I
Kim,S., Jin,H., Seo,H.R., Lee,H.J. and Lee,Y.S. Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation Cell Death Differ (2019) 26, 812-825. PubMed Europe PubMed DOI
Klinngam,W., Janga,S.R., Lee,C., Ju,Y., Yarber,F., Shah,M., Guo,H., Wang,D., MacKay,J.A., Edman,M.C. and Hamm-Alvarez,S.F. Inhibition of cathepsin S reduces lacrimal gland inflammation and increases tear flow in a mouse model of Sjogren's syndrome Sci Rep (2019) 9, 9559-9559. PubMed Europe PubMed DOI I
Lin,H.H., Chen,S.J., Shen,M.R., Huang,Y.T., Hsieh,H.P., Lin,S.Y., Lin,C.C., Chang,W.W. and Chang,J.Y. Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry Biochim Biophys Acta (2019) 1866, 118517-118517. PubMed Europe PubMed DOI K
Shockey,W.A., Kieslich,C.A., Wilder,C.L., Watson,V. and Platt,M.O. Dynamic model of protease state and inhibitor trafficking to predict protease activity in breast cancer cells Cell Mol Bioeng (2019) 12, 275-288. PubMed Europe PubMed DOI PMC EPMC I
Small,D.M., Brown,R.R., Doherty,D.F., Abladey,A., Zhou-Suckow,Z., Delaney,R.J., Kerrigan,L., Dougan,C.M., Borensztajn,K.S., Holsinger,L., Booth,R., Scott,C.J., Lopez-Campos,G., Elborn,J.S., Mall,M.A., Weldon,S. and Taggart,C.C. Targeting of cathepsin S reduces cystic fibrosis-like lung disease Eur Respir J (2019) 53, 1801523-1801523. PubMed Europe PubMed DOI K I
Sugiyama,A., Mitsui,A., Okada,M. and Yamawaki,H. Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats J Vet Med Sci (2019) 81, 522-531. PubMed Europe PubMed DOI
Wang,G.H., He,S.W., Du,X., Xie,B., Gu,Q.Q., Zhang,M. and Hu,Y.H. Characterization, expression, enzymatic activity, and functional identification of cathepsin S from black rockfish Sebastes schlegelii Fish Shellfish Immunol (2019) 93, 623-630. PubMed Europe PubMed DOI
Wartenberg,M., Saidi,A., Galibert,M., Joulin-Giet,A., Burlaud-Gaillard,J., Lecaille,F., Scott,C.J., Aucagne,V., Delmas,A.F. and Lalmanach,G. Imaging of extracellular cathepsin S activity by a selective near infrared fluorescence substrate-based probe Biochimie (2019) 166, 84-93. PubMed Europe PubMed DOI L
Xiao,L., Han,X., Wang,X.E., Li,Q., Chen,Y., Cui,Y. and Chen,Y. Cathepsin S in the spinal microglia facilitates morphine-induced antinociceptive tolerance in rats Neurosci Lett (2019) 690, 225-231. PubMed Europe PubMed DOI
Xu,W., Yu,C., Piao,L., Inoue,A., Wang,H., Meng,X., Li,X., Cui,L., Umegaki,H., Shi,G.P., Murohara,T., Kuzuya,M. and Cheng,X.W. Cathepsin S-mediated negative regulation of Wnt5a/SC35 activation contributes to ischemia-induced neovascularization in aged mice Circ J (2019) 83, 2537-2546. PubMed Europe PubMed DOI
Yang,Y., Lu,J., Yang,C. and Zhang,Y. Exploring fragment-based target-specific ranking protocol with machine learning on cathepsin S J Comput Aided Mol Des (2019) 33, 1095-1105. PubMed Europe PubMed DOI P
Yao,X., Cheng,F., Yu,W., Rao,T., Li,W., Zhao,S., Zhou,X. and Ning,J. Cathepsin S regulates renal fibrosis in mouse models of mild and severe hydronephrosis Mol Med Rep (2019) 20, 141-150. PubMed Europe PubMed DOI

2018

Aich,P. and Biswas,S. Highly conserved Arg residue of ERFNIN motif of pro-domain is important for pH-induced zymogen activation process in cysteine cathepsins K and L Cell Biochem Biophys (2018) 76, 219-229. PubMed Europe PubMed DOI
Chen,C.Y., Chen,C.Y., Liu,C.C. and Chen,C.P. Omega-3 polyunsaturated fatty acids reduce preterm labor by inhibiting trophoblast cathepsin S and inflammasome activation Clin Sci (Lond) (2018) 132, 2221-2239. PubMed Europe PubMed DOI I
Douglas,S.A., Lamothe,S.E., Singleton,T.S., Averett,R.D. and Platt,M.O. Human cathepsins K, L, and S: related proteases, but unique fibrinolytic activity Biochim Biophys Acta (2018) 1862, 1925-1932. PubMed Europe PubMed DOI
Edman,M.C., Janga,S.R., Meng,Z., Bechtold,M., Chen,A.F., Kim,C., Naman,L., Sarma,A., Teekappanavar,N., Kim,A.Y., Madrigal,S., Singh,S., Ortiz,E., Christianakis,S., Arkfeld,D.G., Mack,W.J., Heur,M., Stohl,W. and Hamm-Alvarez,S.F. Increased cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjogren's syndrome patients Sci Rep (2018) 8, 11044-11044. PubMed Europe PubMed DOI PMC EPMC
Gautam,J., Banskota,S., Lee,H., Lee,Y.J., Jeon,Y.H., Kim,J.A. and Jeong,B.S. Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis Exp Mol Med (2018) 50, 118-118. PubMed Europe PubMed DOI
Kubo,K., Kawato,Y., Nakamura,K., Nakajima,Y., Nakagawa,T.Y., Hanaoka,K., Oshima,S., Fukahori,H., Inami,M., Morokata,T. and Higashi,Y. Effective suppression of donor specific antibody production by cathepsin S inhibitors in a mouse transplantation model Eur J Pharmacol (2018) 838, 145-152. PubMed Europe PubMed DOI I
Memmert,S., Nokhbehsaim,M., Damanaki,A., Nogueira,A.V.B., Papadopoulou,A.K., Piperi,C., Basdra,E.K., Rath-Deschner,B., Gotz,W., Cirelli,J.A., Jager,A. and Deschner,J. Role of cathepsin S In periodontal wound healing-an in vitro study on human PDL cells BMC Oral Health (2018) 18, 60-60. PubMed Europe PubMed DOI PMC EPMC
Tber,Z., Wartenberg,M., Jacques,J.E., Roy,V., Lecaille,F., Warszycki,D., Bojarski,A.J., Lalmanach,G. and Agrofoglio,L.A. Selective inhibition of human cathepsin S by 2,4,6-trisubstituted 1,3,5-triazine analogs Bioorg Med Chem (2018) 26, 4310-4319. PubMed Europe PubMed DOI I
Yuan,L., Sheng,L., He,W., Zou,C., Hu,B., Liu,J., Ge,W., Liu,Y., Wang,J. and Ma,E. Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells Bioorg Chem (2018) 81, 672-680. PubMed Europe PubMed DOI I

2017

Ahmad,S. and Siddiqi,M.I. Insights from molecular modeling into the selective inhibition of cathepsin S by its inhibitor J Mol Model (2017) 23, 92-92. PubMed Europe PubMed DOI I
Galibert,M., Wartenberg,M., Lecaille,F., Saidi,A., Mavel,S., Joulin-Giet,A., Korkmaz,B., Bromme,D., Aucagne,V., Delmas,A.F. and Lalmanach,G. Substrate-derived triazolo- and azapeptides as inhibitors of cathepsins K and S Eur J Med Chem (2017) 144, 201-210. PubMed Europe PubMed DOI I
Hsieh,M.J., Lin,C.W., Chen,M.K., Chien,S.Y., Lo,Y.S., Chuang,Y.C., Hsi,Y.T., Lin,C.C., Chen,J.C. and Yang,S.F. Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways Sci Rep (2017) 7, 45039-45039. PubMed Europe PubMed DOI I
Lau,A., Singh,V., Soualhine,H. and Hmama,Z. Expression of cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain Vaccine (2017) 35, 2060-2068. PubMed Europe PubMed DOI U
Li,G.Y., Fu,M., Qin,M. and Xue,L.M. High expression of human cathepsin S by recombinant Pichia pastoris with cod skin as an organic co-nitrogen source J Mol Microbiol Biotechnol (2017) 27, 363-370. PubMed Europe PubMed DOI E
Nubling,G., Schuberth,M., Feldmer,K., Giese,A., Holdt,L.M., Teupser,D. and Lorenzl,S. Cathepsin S increases tau oligomer formation through limited cleavage but only IL-6 not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy Exp Brain Res (2017) 235, 2407-2412. PubMed Europe PubMed DOI
Qi,Z., Huang,B., Zhang,Q., Wang,Z., Wang,P. and Gao,Q. Molecular characterization, expression and evolutionary analysis of 3 cathepsin genes (CTSH, CTSL and CTSS) from Chinese giant salamander (Andrias davidianus) Gene Rep (2017) 7, 25-31. DOI
Regmi,S.C., Samsom,M.L., Heynen,M.L., Jay,G.D., Sullivan,B.D., Srinivasan,S., Caffery,B., Jones,L. and Schmidt,T.A. Degradation of proteoglycan 4/lubricin by cathepsin S: potential mechanism for diminished ocular surface lubrication in Sjogren's syndrome Exp Eye Res (2017) 161, 1-9. PubMed Europe PubMed DOI
Takayama,F., Zhang,X., Hayashi,Y., Wu,Z. and Nakanishi,H. Dysfunction in diurnal synaptic responses and social behavior abnormalities in cathepsin S-deficient mice Biochem Biophys Res Commun (2017) 490, 447-452. PubMed Europe PubMed DOI K
Tato,M., Kumar,S.V., Liu,Y., Mulay,S.R., Moll,S., Popper,B., Eberhard,J.N., Thomasova,D., Rufer,A.C., Gruner,S., Haap,W., Hartmann,G. and Anders,H.J. Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury Sci Rep (2017) 7, 2775-2775. PubMed Europe PubMed DOI PMC EPMC I
Thanei,S., Theron,M., Silva,A.P., Reis,B., Branco,L., Schirmbeck,L., Kolb,F.A., Haap,W., Schindler,T. and Trendelenburg,M. Cathepsin S inhibition suppresses autoimmune-triggered inflammatory responses in macrophages Biochem Pharmacol (2017) 146, 151-164. PubMed Europe PubMed DOI I
Wang,Y., Liu,X., Lv,S., Ren,J. and Ke,F. Identification and activity of a paralog of cathepsin S from yellow catfish (Pelteobagrus fulvidraco) involved in immune response Fish Shellfish Immunol (2017) 61, 16-23. PubMed Europe PubMed DOI
Yan,X., Wu,C., Chen,T., Santos,M.M., Liu,C.L., Yang,C., Zhang,L., Ren,J., Liao,S., Guo,H., Sukhova,G.K. and Shi,G.P. Cathepsin S inhibition changes regulatory T-cell activity in regulating bladder cancer and immune cell proliferation and apoptosis Mol Immunol (2017) 82, 66-74. PubMed Europe PubMed DOI I
Ye,L., Xiao,L., Yang,S.Y., Duan,J.J., Chen,Y., Cui,Y. and Chen,Y. Cathepsin S in the spinal microglia contributes to remifentanil-induced hyperalgesia in rats Neuroscience (2017) 344, 265-275. PubMed Europe PubMed DOI

2016

Akkari,L., Gocheva,V., Quick,M.L., Kester,J.C., Spencer,A.K., Garfall,A.L., Bowman,R.L. and Joyce,J.A. Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer Genes Dev (2016) 30, 220-232. PubMed Europe PubMed DOI PMC EPMC K
Dong,X., Ye,Z., Song,L., Su,B., Zhao,H., Peatman,E. and Li,C. Expression profile analysis of two cathepsin S in channel catfish (Ictalurus punctatus) mucosal tissues following bacterial challenge Fish Shellfish Immunol (2016) 48, 112-118. PubMed Europe PubMed DOI
Fan,W., Shi,W., Zhang,W., Jia,Y., Zhou,Z., Brusnahan,S.K. and Garrison,J.C. Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer Biomaterials (2016) 103, 101-115. PubMed Europe PubMed DOI L
Hewitt,E., Pitcher,T., Rizoska,B., Tunblad,K., Henderson,I., Sahlberg,B.L., Grabowska,U., Classon,B., Edenius,C., Malcangio,M. and Lindstrom,E. Selective cathepsin S inhibition with MIV-247 attenuates mechanical allodynia and enhances the antiallodynic effects of gabapentin and pregabalin in a mouse model of neuropathic pain J Pharmacol Exp Ther (2016) 358, 387-396. PubMed Europe PubMed DOI I
Huang,C.C., Lee,C.C., Lin,H.H. and Chang,J.Y. Cathepsin S attenuates endosomal EGFR signalling: a mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors Sci Rep (2016) 6, 29256-29256. PubMed Europe PubMed DOI PMC EPMC I
Ihmaid,S.K., Ahmed,H.E., Zayed,M.F. and Abadleh,M.M. Self organizing map-based classification of cathepsin K and S inhibitors with different selectivity profiles using different structural molecular fingerprints: design and application for discovery of novel hits Molecules (2016) 21, 175-175. PubMed Europe PubMed DOI I
Kumar Vr,S., Darisipudi,M.N., Steiger,S., Devarapu,S.K., Tato,M., Kukarni,O.P., Mulay,S.R., Thomasova,D., Popper,B., Demleitner,J., Zuchtriegel,G., Reichel,C., Cohen,C.D., Lindenmeyer,M.T., Liapis,H., Moll,S., Reid,E., Stitt,A.W., Schott,B., Gruner,S., Haap,W., Ebeling,M., Hartmann,G. and Anders,H.J. Cathepsin S cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetes complications J Am Soc Nephrol (2016) 27, 1635-1649. PubMed Europe PubMed DOI
Nikolic-Paterson,D.J. Cathepsin S-dependent protease-activated receptor-2 activation: a new mechanism of endothelial dysfunction J Am Soc Nephrol (2016) 27, 1577-1579. PubMed Europe PubMed DOI
Plebanek,E., Chevrier,F., Roy,V., Garenne,T., Lecaille,F., Warszycki,D., Bojarski,A.J., Lalmanach,G. and Agrofoglio,L.A. Straightforward synthesis of 2,4,6-trisubstituted 1,3,5-triazine compounds targeting cysteine cathepsins K and S Eur J Med Chem (2016) 121, 12-20. PubMed Europe PubMed DOI I
Steimle,A., Kalbacher,H., Maurer,A., Beifuss,B., Bender,A., Schafer,A., Muller,R., Autenrieth,I.B. and Frick,J.S. A novel approach for reliable detection of cathepsin S activities in mouse antigen presenting cells J Immunol Methods (2016) 432, 87-94. PubMed Europe PubMed DOI A
Steimle,A., Gronbach,K., Beifuss,B., Schafer,A., Harmening,R., Bender,A., Maerz,J.K., Lange,A., Michaelis,L., Maurer,A., Menz,S., McCoy,K., Autenrieth,I.B., Kalbacher,H. and Frick,J.S. Symbiotic gut commensal bacteria act as host cathepsin S activity regulators J Autoimmun (2016) 75, 82-95. PubMed Europe PubMed DOI
Sun,B.G. and Chi,H. Cathepsin S of Sciaenops ocellatus: identification, transcriptional expression and enzymatic activity Int J Biol Macromol (2016) 82, 76-82. PubMed Europe PubMed DOI
Tjondrokoesoemo,A., Schips,T.G., Sargent,M.A., Vanhoutte,D., Kanisicak,O., Prasad,V., Lin,S.-C.J., Maillet,M. and Molkentin,J.D. Cathepsin S contributes to the pathogenesis of muscular dystrophy in mice J Biol Chem (2016) 291, 9920-9928. PubMed Europe PubMed DOI
Wilkinson,R.D., Young,A., Burden,R.E., Williams,R. and Scott,C.J. A bioavailable cathepsin S nitrile inhibitor abrogates tumor development Mol Cancer (2016) 15, 29-29. PubMed Europe PubMed DOI PMC EPMC I
Woo,S.M., Min,K.J., Seo,B.R. and Kwon,T.K. YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-kappaB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells Oncotarget (2016) 7, 61520-61532. PubMed Europe PubMed DOI
Wu,H., Cheng,X.W., Hu,L., Takeshita,K., Hu,C., Du,Q., Li,X., Zhu,E., Huang,Z., Yisireyili,M., Zhao,G., Piao,L., Inoue,A., Jiang,H., Lei,Y., Zhang,X., Liu,S., Dai,Q., Kuzuya,M., Shi,G.P. and Murohara,T. Cathepsin S activity controls injury-related vascular repair in mice via the TLR2-mediated p38MAPK and PI3K-Akt/p-HDAC6 signaling pathway Arterioscler Thromb Vasc Biol (2016) 36, 1549-1557. PubMed Europe PubMed DOI
Zhou,P.P., Zhang,W.Y., Li,Z.F., Chen,Y.R., Kang,X.C. and Jiang,Y.X. Association between SNPs in the promoter region in cathepsin S and risk of asthma in Chinese Han population Eur Rev Med Pharmacol Sci (2016) 20, 2070-2076. PubMed Europe PubMed M

2015

Andrault,P.M., Samsonov,S.A., Weber,G., Coquet,L., Nazmi,K., Bolscher,J.G., Lalmanach,A.C., Jouenne,T., Bromme,D., Pisabarro,M.T., Lalmanach,G. and Lecaille,F. Antimicrobial peptide LL-37 is both a substrate of cathepsins S and K and a selective inhibitor of cathepsin L Biochemistry (2015) 54, 2785-2798. PubMed Europe PubMed DOI
Barlow,N., Nasser,Y., Zhao,P., Sharma,N., Guerrero-Alba,R., Edgington-Mitchell,L.E., Lieu,T., Veldhuis,N.A., Poole,D.P., Conner,J.W., Lindstrom,E., Craig,A.W., Graham,B., Vanner,S.J. and Bunnett,N.W. Demonstration of elevated levels of active cathepsin S in dextran sulfate sodium colitis using a new activatable probe Neurogastroenterol Motil (2015) 27, 1675-1680. PubMed Europe PubMed DOI L I
Figueiredo,J.L., Aikawa,M., Zheng,C., Aaron,J., Lax,L., Libby,P., de Lima Filho,J.L., Gruener,S., Fingerle,J., Haap,W., Hartmann,G. and Aikawa,E. Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease Am J Pathol (2015) 185, 1156-1166. PubMed Europe PubMed DOI I
Freier,R., Dall,E. and Brandstetter,H. Protease recognition sites in Bet v 1a are cryptic, explaining its slow processing relevant to its allergenicity Sci Rep (2015) 5, 12707-12707. PubMed Europe PubMed DOI PMC EPMC
Kohl,F., Schmitz,J., Furtmann,N., Schulz-Fincke,A.C., Mertens,M.D., Kuppers,J., Benkhoff,M., Tobiasch,E., Bartz,U., Bajorath,J., Stirnberg,M. and Gutschow,M. Design, characterization and cellular uptake studies of fluorescence-labeled prototypic cathepsin inhibitors Org Biomol Chem (2015) 13, 10310-10323. PubMed Europe PubMed DOI I
Li,C., Chen,Q., Jiang,Y. and Liu,Z. Single nucleotide polymorphisms of cathepsin S and the risks of asthma attack induced by acaroid mites Int J Clin Exp Med (2015) 8, 1178-1187. PubMed Europe PubMed PMC EPMC M
Li,Q., Ao,J., Mu,Y., Yang,Z., Li,T., Zhang,X. and Chen,X. Cathepsin S, but not cathepsin L, participates in the MHC class II-associated invariant chain processing in large yellow croaker (Larimichthys crocea) Fish Shellfish Immunol (2015) 47, 743-750. PubMed Europe PubMed DOI
Li,X., Cheng,X.W., Hu,L., Wu,H., Guo-Ping, Hao,C.N., Jiang,H., Zhu,E., Huang,Z., Inoue,A., Sasaki,T., Du,Q., Takeshita,K., Okumura,K., Murohara,T. and Kuzuya,M. Cathepsin S activity controls ischemia-induced neovascularization in mice Int J Cardiol (2015) 183C, 198-208. PubMed Europe PubMed DOI K
Oresic Bender,K., Ofori,L., van der Linden,W.A., Mock,E.D., Datta,G.K., Chowdhury,S., Li,H., Segal,E., Sanchez Lopez,M., Ellman,J.A., Figdor,C.G., Bogyo,M. and Verdoes,M. Design of a highly selective quenched activity-based probe and its application in dual color imaging studies of cathepsin S activity localization J Am Chem Soc (2015) 137, 4771-4777. PubMed Europe PubMed DOI A L
Reddy,V.B., Sun,S., Azimi,E., Elmariah,S.B., Dong,X. and Lerner,E.A. Redefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of Mrgprs Nat Commun (2015) 6, 7864-7864. PubMed Europe PubMed DOI PMC EPMC
Rupanagudi,K.V., Kulkarni,O.P., Lichtnekert,J., Darisipudi,M.N., Mulay,S.R., Schott,B., Gruner,S., Haap,W., Hartmann,G. and Anders,H.J. Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming Ann Rheum Dis (2015) 74, 452-463. PubMed Europe PubMed DOI I
Vazquez,R., Astorgues-Xerri,L., Bekradda,M., Gormley,J., Buick,R., Kerr,P., Cvitkovic,E., Raymond,E., D'Incalci,M., Frapolli,R. and Riveiro,M.E. Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors Biochimie (2015) 108C, 101-107. PubMed Europe PubMed DOI
Wang,X., Xiong,L., Yu,G., Li,D., Peng,T., Luo,D. and Xu,J. Cathepsin S silencing induces apoptosis of human hepatocellular carcinoma cells Am J Transl Res (2015) 7, 100-110. PubMed Europe PubMed PMC EPMC
Wilkinson,R.D., Williams,R., Scott,C.J. and Burden,R.E. Cathepsin S: therapeutic, diagnostic, and prognostic potential Biol Chem (2015) 396, 867-882. PubMed Europe PubMed DOI
Wilkinson,R.D., Magorrian,S.M., Williams,R., Young,A., Small,D.M., Scott,C.J. and Burden,R.E. CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent manner Oncotarget (2015) 6, 29725-29739. PubMed Europe PubMed DOI
Zhang,L., Wang,H. and Xu,J. Cathepsin S as a cancer target Neoplasma (2015) 62, 16-26. PubMed Europe PubMed DOI V T

2014

Cathepsin S mediates brain-specific breast cancer metastasis Cancer Discov (2014) 4, OF11-OF11. DOI
Battu,M.B., Chandra,A.M., Sriram,D. and Yogeeswari,P. Pharmacophore-based 3DQSAR and molecular docking studies to identify new non-peptidic inhibitors of cathepsin S Curr Med Chem (2014) 21, 1910-1921. PubMed Europe PubMed I
Bernard,N.J. Connective tissue diseases. Inhibiting cathepsin S to treat SLE and lupus nephritis Nat Rev Rheumatol (2014) 10, 66-66. PubMed Europe PubMed DOI I
Chua,K.C., Pietsch,M., Zhang,X., Hautmann,S., Chan,H.Y., Bruning,J.B., Gutschow,M. and Abell,A.D. Macrocyclic protease inhibitors with reduced peptide character Angew Chem Int Ed Engl (2014) 53, 7828-7831. PubMed Europe PubMed DOI I
Elmariah,S.B., Reddy,V.B. and Lerner,E.A. Cathepsin S signals via PAR2 and generates a novel tethered ligand receptor agonist PLoS ONE (2014) 9, e99702-e99702. PubMed Europe PubMed DOI PMC EPMC
Hu,H.Y., Vats,D., Vizovisek,M., Kramer,L., Germanier,C., Wendt,K.U., Rudin,M., Turk,B., Plettenburg,O. and Schultz,C. In vivo imaging of mouse tumors by a lipidated cathepsin S substrate Angew Chem Int Ed Engl (2014) 53, 7669-7673. PubMed Europe PubMed DOI L
Jadhav,P.K., Schiffler,M.A., Gavardinas,K., Kim,E.J., Matthews,D.P., Staszak,M.A., Coffey,D.S., Shaw,B.W., Cassidy,K.C., Brier,R.A., Zhang,Y., Christie,R.M., Matter,W.F., Qing,K., Durbin,J.D., Wang,Y. and Deng,G.G. Discovery of cathepsin S inhibitor LY3000328 for the treatment of abdominal aortic aneurysm ACS Med Chem Lett (2014) 5, 1138-1142. PubMed Europe PubMed DOI PMC EPMC I
Kim,M., Jeon,J., Baek,J., Choi,J., Park,E.J., Song,J., Bang,H., Suh,K.H., Kim,Y.H., Kim,J., Kim,D., Min,K.H. and Lee,K.-O. Synthesis of vinyl sulfone-tethered proline derivatives as highly selective cathepsin S inhibitors Bull Korean Chem Soc (2014) 35, 345-346. DOI I
Lafarge,J.C., Pini,M., Pelloux,V., Orasanu,G., Hartmann,G., Venteclef,N., Sulpice,T., Shi,G.P., Clement,K. and Guerre-Millo,M. Cathepsin S inhibition lowers blood glucose levels in mice Diabetologia (2014) 57, 1674-1683. PubMed Europe PubMed DOI I
Mall,M.A. and Schultz,C. A new player in the game: epithelial cathepsin S in early cystic fibrosis lung disease Am J Respir Crit Care Med (2014) 190, 126-127. PubMed Europe PubMed DOI
Payne,C.D., Deeg,M.A., Chan,M., Tan,L.H., LaBell,E.S., Shen,T. and DeBrota,D.J. Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects Br J Clin Pharmacol (2014) 78, 1334-1342. PubMed Europe PubMed DOI I
Rauner,M., Foger-Samwald,U., Kurz,M.F., Brunner-Kubath,C., Schamall,D., Kapfenberger,A., Varga,P., Kudlacek,S., Wutzl,A., Hoger,H., Zysset,P.K., Shi,G.P., Hofbauer,L.C., Sipos,W. and Pietschmann,P. Cathepsin S controls adipocytic and osteoblastic differentiation, bone turnover, and bone microarchitecture Bone (2014) 64, 281-287. PubMed Europe PubMed DOI
Samouillan,V., Revuelta-Lopez,E., Dandurand,J., Nasarre,L., Badimon,L., Lacabanne,C. and Llorente-Cortes,V. Cardiomyocyte intracellular cholesteryl ester accumulation promotes tropoelastin physical alteration and degradation: role of LRP1 and cathepsin S Int J Biochem Cell Biol (2014) 55, 209-219. PubMed Europe PubMed DOI
Sevenich,L., Bowman,R.L., Mason,S.D., Quail,D.F., Rapaport,F., Elie,B.T., Brogi,E., Brastianos,P.K., Hahn,W.C., Holsinger,L.J., Massague,J., Leslie,C.S. and Joyce,J.A. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S Nat Cell Biol (2014) 16, 876-888. PubMed Europe PubMed DOI
Shi,H.T., Wang,Y., Jia,L.X., Qin,Y.W., Liu,Y., Li,H.H., Qi,Y.F. and Du,J. Cathepsin S contributes to macrophage migration via degradation of elastic fibre integrity to facilitate vein graft neointimal hyperplasia Cardiovasc Res (2014) 101, 454-463. PubMed Europe PubMed DOI
Shi,W., Ogbomo,S.M., Wagh,N.K., Zhou,Z., Jia,Y., Brusnahan,S.K. and Garrison,J.C. The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging Biomaterials (2014) 35, 5760-5770. PubMed Europe PubMed DOI P
Tsai,J.Y., Lee,M.J., Chang,M.D., Wang,H.C., Lin,C.C. and Huang,H. Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells J Enzyme Inhib Med Chem (2014) 29, 538-546. PubMed Europe PubMed DOI I
Zhao,P., Lieu,T., Barlow,N., Metcalf,M., Veldhuis,N.A., Jensen,D.D., Kocan,M., Sostegni,S., Haerteis,S., Baraznenok,V., Henderson,I., Lindstrom,E., Guerrero-Alba,R., Valdez-Morales,E.E., Liedtke,W., McIntyre,P., Vanner,S.J., Korbmacher,C. and Bunnett,N.W. Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4 J Biol Chem (2014) 289, 27215-27234. PubMed Europe PubMed DOI

2013

Caglic,D., Repnik,U., Jedeszko,C., Kosec,G., Miniejew,C., Kindermann,M., Vasiljeva,O., Turk,V., Wendt,K.U., Sloane,B.F., Goldring,M.B. and Turk,B. The proinflammatory cytokines interleukin-1alpha and tumor necrosis factor alpha promote the expression and secretion of proteolytically active cathepsin S from human chondrocytes Biol Chem (2013) 394, 307-316. PubMed Europe PubMed DOI
Chen,H., Wang,J., Xiang,M.X., Lin,Y., He,A., Jin,C.N., Guan,J., Sukhova,G.K., Libby,P., Wang,J.A. and Shi,G.P. Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction Cardiovasc Res (2013) 100, 84-94. PubMed Europe PubMed DOI
Feth,M.P., Heyse,W., Baumgartner,B., Nagel,N., Tappertzhofen,C., Olpp,T., Jurascheck,J., Ulrich,J., Helmdach,L. and Petzoldt,C. From laboratory to pilot plant: the solid-state process development of a highly potent cathepsin S/K inhibitor Eur J Pharm Biopharm (2013) 83, 436-448. PubMed Europe PubMed DOI I
Fonovic,U.P., Jevnikar,Z. and Kos,J. Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells Biol Chem (2013) 394, 1349-1352. PubMed Europe PubMed DOI
Hayashi,Y., Koyanagi,S., Kusunose,N., Okada,R., Wu,Z., Tozaki-Saitoh,H., Ukai,K., Kohsaka,S., Inoue,K., Ohdo,S. and Nakanishi,H. The intrinsic microglial molecular clock controls synaptic strength via the circadian expression of cathepsin S Sci Rep (2013) 3, 2744-2744. PubMed Europe PubMed DOI PMC EPMC
Hilpert,H., Mauser,H., Humm,R., Anselm,L., Kuehne,H., Hartmann,G., Gruener,S., Banner,D.W., Benz,J., Gsell,B., Kuglstatter,A., Stihle,M., Thoma,R., Sanchez,R.A., Iding,H., Wirz,B. and Haap,W. Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds J Med Chem (2013) 56, 9789-9801. PubMed Europe PubMed DOI I
Huang,C.C., Chen,K.L., Cheung,C.H. and Chang,J.Y. Autophagy induced by cathepsin S inhibition induces early ROS production, oxidative DNA damage, and cell death via xanthine oxidase Free Radic Biol Med (2013) 65, 1473-1486. PubMed Europe PubMed DOI I
Kim,M., Jeon,J., Song,J., Suh,K.H., Kim,Y.H., Min,K.H. and Lee,K.O. Synthesis of proline analogues as potent and selective cathepsin S inhibitors Bioorg Med Chem Lett (2013) 23, 3140-3144. PubMed Europe PubMed DOI I
Lecaille,F., Naudin,C., Sage,J., Joulin-Giet,A., Courty,A., Andrault,P.M., Veldhuizen,R.A., Possmayer,F. and Lalmanach,G. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties Int J Biochem Cell Biol (2013) 45, 1701-1709. PubMed Europe PubMed DOI
Ou,Z., Wang,G., Li,Q., Ma,Z., Lin,D., Dai,M. and Zou,F. The genetic polymorphisms of cathepsin S were associated with metabolic disorders in a Chinese Han population Gene (2013) 526, 385-389. PubMed Europe PubMed DOI M
Pehere,A.D., Pietsch,M., Gutschow,M., Neilsen,P.M., Pedersen,D.S., Nguyen,S., Zvarec,O., Sykes,M.J., Callen,D.F. and Abell,A.D. Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors Chemistry (2013) 19, 7975-7981. PubMed Europe PubMed DOI I
Sage,J., Mallevre,F., Barbarin-Costes,F., Samsonov,S.A., Gehrcke,J.P., Pisabarro,M.T., Perrier,E., Schnebert,S., Roget,A., Livache,T., Nizard,C., Lalmanach,G. and Lecaille,F. Binding of chondroitin 4-sulfate to cathepsin S regulates its enzymatic activity Biochemistry (2013) 52, 6487-6498. PubMed Europe PubMed DOI
Small,D.M., Burden,R.E., Jaworski,J., Hegarty,S.M., Spence,S., Burrows,J.F., McFarlane,C., Kissenpfennig,A., McCarthy,H.O., Johnston,J.A., Walker,B. and Scott,C.J. Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization Int J Cancer (2013) 133, 2102-2112. PubMed Europe PubMed DOI K T
Wiener,J.J., Wickboldt,A.T., Nguyen,S., Sun,S., Rynberg,R., Rizzolio,M., Karlsson,L., Edwards,J.P. and Grice,C.A. Pyrazole-based arylalkyne cathepsin S inhibitors. Part III: modification of P4 region Bioorg Med Chem Lett (2013) 23, 1070-1074. PubMed Europe PubMed DOI I
Xu,J., Wang,H., Ding,K., Lu,X., Li,T., Wang,J., Wang,C. and Wang,J. Inhibition of cathepsin S produces neuroprotective effects after traumatic brain injury in mice Mediators Inflamm (2013) 2013, 187873-187873. PubMed Europe PubMed DOI PMC EPMC I

2012

Arnlov,J. Cathepsin S as a biomarker: where are we now and what are the future challenges? Biomark Med (2012) 6, 9-11. PubMed Europe PubMed DOI
Barry,Z.T. and Platt,M.O. Cathepsin S cannibalism of cathepsin K as a mechanism to reduce type I collagen degradation J Biol Chem (2012) 287, 27723-27730. PubMed Europe PubMed DOI
Burden,R.E., Gormley,J.A., Kuehn,D., Ward,C., Kwok,H.F., Gazdoiu,M., McClurg,A., Jaquin,T.J., Johnston,J.A., Scott,C.J. and Olwill,S.A. Inhibition of cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas Biochimie (2012) 94, 487-493. PubMed Europe PubMed DOI
Chen,K.L., Chang,W.S., Cheung,C.H., Lin,C.C., Huang,C.C., Yang,Y.N., Kuo,C.P., Kuo,C.C., Chang,Y.H., Liu,K.J., Wu,C.M. and Chang,J.Y. Targeting cathepsin S induces tumor cell autophagy via the EGFR-Erk signaling pathway Cancer Lett (2012) 317, 89-98. PubMed Europe PubMed DOI I
Clark,A.K. and Malcangio,M. Microglial signalling mechanisms: cathepsin S and fractalkine Exp Neurol (2012) 234, 283-292. PubMed Europe PubMed DOI
Fan,Q., Wang,X., Zhang,H., Li,C., Fan,J. and Xu,J. Silencing cathepsin S gene expression inhibits growth, invasion and angiogenesis of human hepatocellular carcinoma in vitro Biochem Biophys Res Commun (2012) 425, 703-710. PubMed Europe PubMed DOI K T
Frizler,M., Schmitz,J., Schulz-Fincke,A.C. and Gutschow,M. Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F J Med Chem (2012) 55, 5982-5986. PubMed Europe PubMed DOI I
Fujii,H., Ivison,S.M., Shimizu,H., Kajiwara,R., Kariminia,A., Yan,M., Dutz,J.P. and Schultz,K.R. Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens Biol Blood Marrow Transplant (2012) 18, 546-556. PubMed Europe PubMed DOI I
Haerteis,S., Krappitz,M., Bertog,M., Krappitz,A., Baraznenok,V., Henderson,I., Lindstrom,E., Murphy,J.E., Bunnett,N.W. and Korbmacher,C. Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S Pflugers Arch (2012) 464, 353-365. PubMed Europe PubMed DOI
Kim,N., Bae,K.B., Kim,M.O., Yu,D.H., Kim,H.J., Yuh,H.S., Ji,Y.R., Park,S.J., Kim,S., Son,K.H., Park,S.J., Yoon,D., Lee,D.S., Lee,S., Lee,H.S., Kim,T.Y. and Ryoo,Z.Y. Overexpression of cathepsin S induces chronic atopic dermatitis in mice J Invest Dermatol (2012) 132, 1169-1176. PubMed Europe PubMed DOI
Kirschke,H. Cathepsin S [ISSN:978-0-12-407743-0] (2012) 3, 1824-1830. DOI
Moss,N., Xiong,Z., Burke,M., Cogan,D., Gao,D.A., Haverty,K., Heim-Riether,A., Hickey,E.R., Nagaraja,R., Netherton,M., O'Shea,K., Ramsden,P., Schwartz,R., Shih,D.T., Ward,Y., Young,E. and Zhang,Q. Exploration of cathepsin S inhibitors characterized by a triazole P1-P2 amide replacement Bioorg Med Chem Lett (2012) 22, 7189-7193. PubMed Europe PubMed DOI I
Oliveira,M., Assis,D.M., Paschoalin,T., Miranda,A., Ribeiro,E.B., Juliano,M.A., Bromme,D., Christoffolete,M.A., Barros,N.M. and Carmona,A.K. Cysteine cathepsin S processes leptin, inactivating its biological activity J Endocrinol (2012) 214, 217-224. PubMed Europe PubMed DOI
Pan,L., Li,Y., Jia,L., Qin,Y., Qi,G., Cheng,J., Qi,Y., Li,H. and Du,J. Cathepsin S deficiency results in abnormal accumulation of autophagosomes in macrophages and enhances Ang II-induced cardiac inflammation PLoS ONE (2012) 7, e35315-e35315. PubMed Europe PubMed DOI PMC EPMC K
Qin,Y., Cao,X., Guo,J., Zhang,Y., Pan,L., Zhang,H., Li,H., Tang,C., Du,J. and Shi,G.P. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice Cardiovasc Res (2012) 96, 401-410. PubMed Europe PubMed DOI K
Sage,J., Leblanc-Noblesse,E., Nizard,C., Sasaki,T., Schnebert,S., Perrier,E., Kurfurst,R., Bromme,D., Lalmanach,G. and Lecaille,F. Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners PLoS ONE (2012) 7, e43494-e43494. PubMed Europe PubMed DOI PMC EPMC
Stoeckle,C., Quecke,P., Ruckrich,T., Burster,T., Reich,M., Weber,E., Kalbacher,H., Driessen,C., Melms,A. and Tolosa,E. Cathepsin S dominates autoantigen processing in human thymic dendritic cells J Autoimmun (2012) 38, 332-343. PubMed Europe PubMed DOI
Verdoes,M., Edgington,L.E., Scheeren,F.A., Leyva,M., Blum,G., Weiskopf,K., Bachmann,M.H., Ellman,J.A. and Bogyo,M. A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages Chem Biol (2012) 19, 619-628. PubMed Europe PubMed DOI PMC EPMC L
Zhou,J., Li,L. and Cai,Z.H. Identification of putative cathepsin S in mangrove red snapper Lutjanus argentimaculatus and its role in antigen presentation Dev Comp Immunol (2012) 37, 28-38. PubMed Europe PubMed DOI

2011

Baugh,M., Black,D., Westwood,P., Kinghorn,E., McGregor,K., Bruin,J., Hamilton,W., Dempster,M., Claxton,C., Cai,J., Bennett,J., Long,C., McKinnon,H., Vink,P., Hoed,L., Gorecka,M., Vora,K., Grant,E., Percival,M.D., Boots,A.M. and van Lierop,M.J. Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity J Autoimmun (2011) 36, 201-209. PubMed Europe PubMed DOI I
Biniossek,M.L., Nagler,D.K., Becker-Pauly,C. and Schilling,O. Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S J Proteome Res (2011) 10, 5363-5373. PubMed Europe PubMed DOI P
Caglic,D., Globisch,A., Kindermann,M., Lim,N.H., Jeske,V., Juretschke,H.P., Bartnik,E., Weithmann,K.U., Nagase,H., Turk,B. and Wendt,K.U. Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation Bioorg Med Chem (2011) 19, 1055-1061. PubMed Europe PubMed DOI L
Deschamps,K., Cromlish,W., Weicker,S., Lamontagne,S., Huszar,S.L., Gauthier,J.Y., Mudgett,J.S., Guimond,A., Romand,R., Frossard,N., Percival,M.D., Slipetz,D. and Tan,C.M. Genetic and pharmacological evaluation of cathepsin S in a mouse model of asthma Am J Respir Cell Mol Biol (2011) 45, 81-87. PubMed Europe PubMed DOI K I
Jiang,C., Sun,W., Zhou,X.P. and Yang,X.H. Cathepsin S inhibitors and the structure-activity relationship: research advances J Int Pharm Res (2011) 38, 182-188. I
Kerns,J.K., Nie,H., Bondinell,W., Widdowson,K.L., Yamashita,D.S., Rahman,A., Podolin,P.L., Carpenter,D.C., Jin,Q., Riflade,B., Dong,X., Nevins,N., Keller,P.M., Mitchell,L. and Tomaszek,T. Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent Bioorg Med Chem Lett (2011) 21, 4409-4415. PubMed Europe PubMed DOI I
Kwok,H.F., Buick,R.J., Kuehn,D., Gormley,J.A., Doherty,D., Jaquin,T.J., McClurg,A., Ward,C., Byrne,T., Jaworski,J., Leung,K.L., Snoddy,P., McAnally,C., Burden,R.E., Gray,B., Lowry,J., Sermadiras,I., Gruszka,N., Courtenay-Luck,N., Kissenpfennig,A., Scott,C.J., Johnston,J.A. and Olwill,S.A. Antibody targeting of cathepsin S induces antibody-dependent cellular cytotoxicity Mol Cancer (2011) 10, 147-147. PubMed Europe PubMed DOI
Lee-Dutra,A., Wiener,D.K. and Sun,S. Cathepsin S inhibitors: 2004 - 2010 Expert Opin Ther Pat (2011) 21, 311-337. PubMed Europe PubMed DOI V I
Loser,R. Cathepsin S inhibitors: WO2010070615 Expert Opin Ther Pat (2011) 21, 585-591. PubMed Europe PubMed DOI I
Schechter,I. and Ziv,E. Cathepsins S, B and L with aminopeptidases display beta-secretase activity associated with the pathogenesis of Alzheimer's disease Biol Chem (2011) 392, 555-569. PubMed Europe PubMed DOI
Small,D.M., Burden,R.E. and Scott,C.J. The emerging relevance of the cysteine protease cathepsin S in disease Clin Rev Bone Miner Metab (2011) 9, 122-132. DOI V
Sun,Y.N., Xu,T.J., Wang,J.X., Cheng,Y.Z. and Wang,R.X. Sequence and expression analysis of cathepsin S gene in the miiuy croaker Miichthys miiuy Fish Physiol Biochem (2011) 37, 761-765. PubMed Europe PubMed DOI
Veilleux,A., Black,W.C., Gauthier,J.Y., Mellon,C., Percival,M.D., Tawa,P. and Falgueyret,J.P. Probing cathepsin S activity in whole blood by the activity-based probe BIL-DMK: cellular distribution in human leukocyte populations and evidence of diurnal modulation Anal Biochem (2011) 411, 43-49. PubMed Europe PubMed DOI I

2010

Ameriks,M.K., Bembenek,S.D., Burdett,M.T., Choong,I.C., Edwards,J.P., Gebauer,D., Gu,Y., Karlsson,L., Purkey,H.E., Staker,B.L., Sun,S., Thurmond,R.L. and Zhu,J. Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors Bioorg Med Chem Lett (2010) 20, 4060-4064. PubMed Europe PubMed DOI I
Cai,J., Robinson,J., Belshaw,S., Everett,K., Fradera,X., van Zeeland,M., van Berkom,L., van Rijnsbergen,P., Popplestone,L., Baugh,M., Dempster,M., Bruin,J., Hamilton,W., Kinghorn,E., Westwood,P., Kerr,J., Rankovic,Z., Arbuckle,W., Bennett,D.J., Jones,P.S., Long,C., Martin,I., Uitdehaag,J.C. and Meulemans,T. Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors Bioorg Med Chem Lett (2010) 20, 6890-6894. PubMed Europe PubMed DOI I
Cai,J., Baugh,M., Black,D., Long,C., Jonathan Bennett,D., Dempster,M., Fradera,X., Gillespie,J., Andrews,F., Boucharens,S., Bruin,J., Cameron,K.S., Cumming,I., Hamilton,W., Jones,P.S., Kaptein,A., Kinghorn,E., Maidment,M., Martin,I., Mitchell,A., Rankovic,Z., Robinson,J., Scullion,P., Uitdehaag,J.C., Vink,P., Westwood,P., van Zeeland,M., van Berkom,L., Bastiani,M. and Meulemans,T. 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors Bioorg Med Chem Lett (2010) 20, 4350-4354. PubMed Europe PubMed DOI I
Cai,J., Bennett,D.J., Rankovic,Z., Dempster,M., Fradera,X., Gillespie,J., Cumming,I., Finlay,W., Baugh,M., Boucharens,S., Bruin,J., Cameron,K.S., Hamilton,W., Kerr,J., Kinghorn,E., McGarry,G., Robinson,J., Scullion,P., Uitdehaag,J.C., van Zeeland,M., Potin,D., Saniere,L., Fouquet,A., Chevallier,F., Deronzier,H., Dorleans,C. and Nicolai,E. 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors Bioorg Med Chem Lett (2010) 20, 4447-4450. PubMed Europe PubMed DOI I
Cai,J., Fradera,X., van Zeeland,M., Dempster,M., Cameron,K.S., Bennett,D.J., Robinson,J., Popplestone,L., Baugh,M., Westwood,P., Bruin,J., Hamilton,W., Kinghorn,E., Long,C. and Uitdehaag,J.C. 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important Bioorg Med Chem Lett (2010) 20, 4507-4510. PubMed Europe PubMed DOI I
Chen,J.C., Uang,B.J., Lyu,P.C., Chang,J.Y., Liu,K.J., Kuo,C.C., Hsieh,H.P., Wang,H.C., Cheng,C.S., Chang,Y.H., Chang,M.D., Chang,W.S. and Lin,C.C. Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis J Med Chem (2010) 53, 4545-4549. PubMed Europe PubMed DOI I
Coppini,L.P., Barros,N.M., Oliveira,M., Hirata,I.Y., Alves,M.F., Paschoalin,T., Assis,D.M., Juliano,M.A., Puzer,L., Bromme,D. and Carmona,A.K. Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitor Biol Chem (2010) 391, 561-570. PubMed Europe PubMed DOI P
Frizler,M., Stirnberg,M., Sisay,M.T. and Gutschow,M. Development of nitrile-based peptidic inhibitors of cysteine cathepsins Curr Top Med Chem (2010) 10, 294-322. PubMed Europe PubMed DOI T I
Isabel,E., Bateman,K.P., Chauret,N., Cromlish,W., Desmarais,S., Duong,l.T., Falgueyret,J.P., Gauthier,J.Y., Lamontagne,S., Lau,C.K., Leger,S., LeRiche,T., Levesque,J.F., Li,C.S., Masse,F., McKay,D.J., Mellon,C., Nicoll-Griffith,D.A., Oballa,R.M., Percival,M.D., Riendeau,D., Robichaud,J., Rodan,G.A., Rodan,S.B., Seto,C., Therien,M., Truong,V.L., Wesolowski,G., Young,R.N., Zamboni,R. and Black,W.C. The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor Bioorg Med Chem Lett (2010) 20, 887-892. PubMed Europe PubMed DOI I
Jobs,E., Riserus,U., Ingelsson,E., Helmersson,J., Nerpin,E., Jobs,M., Sundstrom,J., Lind,L., Larsson,A., Basu,S. and Arnlov,J. Serum Cathepsin S Is Associated with Serum C-Reactive Protein and Interleukin-6 Independently of Obesity in Elderly Men J Clin Endocrinol Metab (2010) 95, 4460-4464. PubMed Europe PubMed DOI
Kim,N.Y., Ahn,S.J., Lee,A.R., Seo,J.S., Kim,M.S., Kim,J.K., Chung,J.K. and Lee,H.H. Cloning, expression analysis and enzymatic characterization of cathepsin S from olive flounder (Paralichthys olivaceus) Comp Biochem Physiol B Biochem Mol Biol (2010) 157, 238-247. PubMed Europe PubMed DOI
Lee-Dutra,A., Wiener,D.K., Arienti,K.L., Liu,J., Mani,N., Ameriks,M.K., Axe,F.U., Gebauer,D., Desai,P.J., Nguyen,S., Randal,M., Thurmond,R.L., Sun,S., Karlsson,L., Edwards,J.P., Jones,T.K. and Grice,C.A. Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: Part 1 Bioorg Med Chem Lett (2010) 20, 2370-2374. PubMed Europe PubMed DOI I
Li,C., Jiang,Y. and Li,L. A hypothesis - peptide library generated by cathepsin S might be efficacious for allergen-specific immunotherapy Vaccine (2010) 28, 1135-1137. PubMed Europe PubMed DOI
Naour,N., Rouault,C., Fellahi,S., Lavoie,M.E., Poitou,C., Keophiphath,M., Eberle,D., Shoelson,S., Rizkalla,S., Bastard,J.P., Rabasa-Lhoret,R., Clement,K. and Guerre-Millo,M. Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin S in adipose tissue and in circulation J Clin Endocrinol Metab (2010) 95, 1861-1868. PubMed Europe PubMed DOI
Oliveira,M., Torquato,R.J., Alves,M.F., Juliano,M.A., Bromme,D., Barros,N.M. and Carmona,A.K. Improvement of cathepsin S detection using a designed FRET peptide based on putative natural substrates Peptides (2010) 31, 562-567. PubMed Europe PubMed DOI A
Piovan,L., Alves,M.F.M., Juliano,L., Bromme,D., Cunha,R.L.O.R. and Andrade,L.H. Chemoenzymatic synthesis of organoselenium(IV) compounds and their evaluation as cysteine protease inhibitors J Braz Chem Soc (2010) 21, 2108-2118. I
Reddy,V.B., Shimada,S.G., Sikand,P., LaMotte,R.H. and Lerner,E.A. Cathepsin S elicits itch and signals via protease-activated receptors J Invest Dermatol (2010) 130, 1468-1470. PubMed Europe PubMed DOI
Samokhin,A.O., Lythgo,P.A., Gauthier,J.Y., Percival,M.D. and Bromme,D. Pharmacological inhibition of cathepsin S decreases atherosclerotic lesions in Apoe-/- mice J Cardiovasc Pharmacol (2010) 56, 98-105. PubMed Europe PubMed DOI I
Ward,C., Kuehn,D., Burden,R.E., Gormley,J.A., Jaquin,T.J., Gazdoiu,M., Small,D., Bicknell,R., Johnston,J.A., Scott,C.J. and Olwill,S.A. Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF PLoS ONE (2010) 5, e12543-e12543. PubMed Europe PubMed DOI PMC EPMC
Wiener,D.K., Lee-Dutra,A., Bembenek,S., Nguyen,S., Thurmond,R.L., Sun,S., Karlsson,L., Grice,C.A., Jones,T.K. and Edwards,J.P. Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors Bioorg Med Chem Lett (2010) 20, 2379-2382. PubMed Europe PubMed DOI I
Wiener,J.J., Wickboldt,A.T., Jr., Wiener,D.K., Lee-Dutra,A., Edwards,J.P., Karlsson,L., Nguyen,S., Sun,S., Jones,T.K. and Grice,C.A. Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regions Bioorg Med Chem Lett (2010) 20, 2375-2378. PubMed Europe PubMed DOI I
Wiener,J.J., Sun,S. and Thurmond,R.L. Recent advances in the design of cathepsin S inhibitors Curr Top Med Chem (2010) 10, 717-732. PubMed Europe PubMed DOI V I
Yang,Y., Yixuan,Y., Lim,S.K., Kiat,L.S., Choong,L.Y., Yee,C.L., Lee,H., Huiyin,L., Chen,Y., Yunhao,C., Chong,P.K., Kuan,C.P., Ashktorab,H., Hassan,A., Wang,T.T., Ting,W.T., Salto-Tellez,M., Manuel,S.T., Yeoh,K.G., Guan,Y.K., Lim,Y.P. and Pin,L.Y. Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins J Proteome Res (2010) 9, 4767-4778. PubMed Europe PubMed DOI

2009

Aikawa,E., Aikawa,M., Libby,P., Figueiredo,J.L., Rusanescu,G., Iwamoto,Y., Fukuda,D., Kohler,R.H., Shi,G.P., Jaffer,F.A. and Weissleder,R. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease Circulation (2009) 119, 1785-1794. PubMed Europe PubMed DOI PMC EPMC K
Ameriks,M.K., Axe,F.U., Bembenek,S.D., Edwards,J.P., Gu,Y., Karlsson,L., Randal,M., Sun,S., Thurmond,R.L. and Zhu,J. Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements Bioorg Med Chem Lett (2009) 19, 6131-6134. PubMed Europe PubMed DOI S I
Ameriks,M.K., Cai,H., Edwards,J.P., Gebauer,D., Gleason,E., Gu,Y., Karlsson,L., Nguyen,S., Sun,S., Thurmond,R.L. and Zhu,J. Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: Optimization of cellular potency Bioorg Med Chem Lett (2009) 19, 6135-6139. PubMed Europe PubMed DOI I
Ayesa,S., Lindquist,C., Agback,T., Benkestock,K., Classon,B., Henderson,I., Hewitt,E., Jansson,K., Kallin,A., Sheppard,D. and Samuelsson,B. Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity Bioorg Med Chem (2009) 17, 1307-1324. PubMed Europe PubMed DOI I
Bethel,P.A., Gerhardt,S., Jones,E.V., Kenny,P.W., Karoutchi,G.I., Morley,A.D., Oldham,K., Rankine,N., Augustin,M., Krapp,S., Simader,H. and Steinbacher,S. Design of selective cathepsin inhibitors Bioorg Med Chem Lett (2009) 19, 4622-4625. PubMed Europe PubMed DOI I
Burden,R.E., Gormley,J.A., Jaquin,T.J., Small,D.M., Quinn,D.J., Hegarty,S.M., Ward,C., Walker,B., Johnston,J.A., Olwill,S.A. and Scott,C.J. Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis Clin Cancer Res (2009) 15, 6042-6051. PubMed Europe PubMed DOI T
Clark,A.K., Yip,P.K. and Malcangio,M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S J Neurosci (2009) 29, 6945-6954. PubMed Europe PubMed DOI PMC EPMC I
Costantino,C.M., Ploegh,H.L. and Hafler,D.A. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells J Immunol (2009) 183, 945-952. PubMed Europe PubMed DOI PMC EPMC
de Nooijer,R., Bot,I., von der Thusen,J.H., Leeuwenburgh,M.A., Overkleeft,H.S., Kraaijeveld,A.O., Dorland,R., van Santbrink,P.J., van Heiningen,S.H., Westra,M.M., Kovanen,P.T., Jukema,J.W., van der Wall,E.E., van Berkel,T.J., Shi,G.P. and Biessen,E.A. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis Arterioscler Thromb Vasc Biol (2009) 29, 188-194. PubMed Europe PubMed DOI
Jordans,S., Jenko-Kokalj,S., Kuhl,N.M., Tedelind,S., Sendt,W., Bromme,D., Turk,D. and Brix,K. Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions BMC Biochem (2009) 10, 23-23. PubMed Europe PubMed DOI PMC EPMC
Polyakova,O., Dear,D., Stern,I., Martin,S., Hirst,E., Bawumia,S., Nash,A., Dodson,G., Bronstein,I. and Bayley,P.M. Proteolysis of prion protein by cathepsin S generates a soluble beta-structured intermediate oligomeric form, with potential implications for neurotoxic mechanisms Eur Biophys J (2009) 38, 209-218. PubMed Europe PubMed DOI
Schilling,K., Korner,A., Sehmisch,S., Kreusch,A., Kleint,R., Benedix,Y., Schlabrakowski,A. and Wiederanders,B. Selectivity of propeptide-enzyme interaction in cathepsin L-like cysteine proteases Biol Chem (2009) 390, 167-174. PubMed Europe PubMed DOI
Vinardell,T., Dejica,V., Poole,A.R., Mort,J.S., Richard,H. and Laverty,S. Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis Osteoarthritis Cartilage (2009) 17, 375-383. PubMed Europe PubMed DOI

2008

Gupta,S., Singh,R.K., Dastidar,S. and Ray,A. Cysteine cathepsin S as an immunomodulatory target: present and future trends Expert Opin Ther Targets (2008) 12, 291-299. PubMed Europe PubMed DOI
Irie,O., Ehara,T., Iwasaki,A., Yokokawa,F., Sakaki,J., Hirao,H., Kanazawa,T., Teno,N., Horiuchi,M., Umemura,I., Gunji,H., Masuya,K., Hitomi,Y., Iwasaki,G., Nonomura,K., Tanabe,K., Fukaya,H., Kosaka,T., Snell,C.R. and Hallett,A. Discovery of selective and nonpeptidic cathepsin S inhibitors Bioorg Med Chem Lett (2008) 18, 3959-3962. PubMed Europe PubMed DOI I
Irie,O., Yokokawa,F., Ehara,T., Iwasaki,A., Iwaki,Y., Hitomi,Y., Konishi,K., Kishida,M., Toyao,A., Masuya,K., Gunji,H., Sakaki,J., Iwasaki,G., Hirao,H., Kanazawa,T., Tanabe,K., Kosaka,T., Hart,T.W. and Hallett,A. 4-Amino-2-cyanopyrimidines: novel scaffold for nonpeptidic cathepsin S inhibitors Bioorg Med Chem Lett (2008) 18, 4642-4646. PubMed Europe PubMed DOI I
Irie,O., Kosaka,T., Ehara,T., Yokokawa,F., Kanazawa,T., Hirao,H., Iwasaki,A., Sakaki,J., Teno,N., Hitomi,Y., Iwasaki,G., Fukaya,H., Nonomura,K., Tanabe,K., Koizumi,S., Uchiyama,N., Bevan,S.J., Malcangio,M., Gentry,C., Fox,A.J., Yaqoob,M., Culshaw,A.J. and Allan,H. Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain J Med Chem (2008) 51, 5502-5505. PubMed Europe PubMed DOI I
Irie,O., Kosaka,T., Kishida,M., Sakaki,J., Masuya,K., Konishi,K., Yokokawa,F., Ehara,T., Iwasaki,A., Iwaki,Y., Hitomi,Y., Toyao,A., Gunji,H., Teno,N., Iwasaki,G., Hirao,H., Kanazawa,T., Tanabe,K., Hiestand,P.C., Malcangio,M., Fox,A.J., Bevan,S.J., Yaqoob,M., Culshaw,A.J., Hart,T.W. and Hallett,A. Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-cyanopyrimidines. Part 2 Bioorg Med Chem Lett (2008) 18, 5280-5284. PubMed Europe PubMed DOI I
Lutzner,N. and Kalbacher,H. Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate J Biol Chem (2008) 283, 36185-36194. PubMed Europe PubMed DOI PMC EPMC A
Markt,P., McGoohan,C., Walker,B., Kirchmair,J., Feldmann,C., De Martino,G., Spitzer,G., Distinto,S., Schuster,D., Wolber,G., Laggner,C. and Langer,T. Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening J Chem Inf Model (2008) 48, 1693-1705. PubMed Europe PubMed DOI I
Minematsu,N., Nakamura,H., Furuuchi,M., Nakajima,T., Takahashi,S., Tsujimura,S., Tateno,H. and Ishizaka,A. Common functional polymorphisms in the cathepsin S promoter in Japanese subjects: possible contribution to pulmonary emphysema Respirology (2008) 13, 498-504. PubMed Europe PubMed DOI M
Spielmann,N., Mutch,D.M., Rousseau,F., Tores,F., Hager,J., Bertrais,S., Basdevant,A., Tounian,P., Dubern,B., Galan,P. and Clement,K. Cathepsin S genotypes are associated with Apo-A1 and HDL-cholesterol in lean and obese French populations Clin Genet (2008) 74, 155-163. PubMed Europe PubMed DOI M
Tiribuzi,R., Martino,S., Ciraci,E., D'Angelo,F., Girolamo,D., Datti,A., Bottazzo,G.F., Berardi,A.C. and Orlacchio,A. Non-redundant roles of cathepsins L, B and S in CD1a+ dendritic cells knocked-down for cathepsin S by RNA interference Minerva Biotecnol (2008) 20, 59-67.

2007

Alves,F.M., Hirata,I.Y., Gouvea,I.E., Alves,M.F., Meldal,M., Bromme,D., Juliano,L. and Juliano,M.A. Controlled peptide solvation in portion-mixing libraries of FRET peptides: improved specificity determination for dengue 2 virus NS2B-NS3 protease and human cathepsin S J Comb Chem (2007) 9, 627-634. PubMed Europe PubMed DOI
Bekkali,Y., Thomson,D.S., Betageri,R., Emmanuel,M.J., Hao,M.H., Hickey,E., Liu,W., Patel,U., Ward,Y.D., Young,E.R., Nelson,R., Kukulka,A., Brown,M.L., Crane,K., White,D., Freeman,D.M., Labadia,M.E., Wildeson,J. and Spero,D.M. Identification of a novel class of succinyl-nitrile-based cathepsin S inhibitors Bioorg Med Chem Lett (2007) 17, 2465-2469. PubMed Europe PubMed DOI I
Chatterjee,A.K., Liu,H., Tully,D.C., Guo,J., Epple,R., Russo,R., Williams,J., Roberts,M., Tuntland,T., Chang,J., Gordon,P., Hollenbeck,T., Tumanut,C., Li,J. and Harris,J.L. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S Bioorg Med Chem Lett (2007) 17, 2899-2903. PubMed Europe PubMed DOI I
Clark,A.K., Yip,P.K., Grist,J., Gentry,C., Staniland,A.A., Marchand,F., Dehvari,M., Wotherspoon,G., Winter,J., Ullah,J., Bevan,S. and Malcangio,M. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain Proc Natl Acad Sci U S A (2007) 104, 10655-10660. PubMed Europe PubMed DOI PMC EPMC I
Gauthier,J.Y., Black,W.C., Courchesne,I., Cromlish,W., Desmarais,S., Houle,R., Lamontagne,S., Li,C.S., Masse,F., McKay,D.J., Ouellet,M., Robichaud,J., Truchon,J.F., Truong,V.L., Wang,Q. and Percival,M.D. The identification of potent, selective, and bioavailable cathepsin S inhibitors Bioorg Med Chem Lett (2007) 17, 4929-4933. PubMed Europe PubMed DOI I
Hirakawa,H., Pierce,R.A., Bingol-Karakoc,G., Karaaslan,C., Weng,M., Shi,G.P., Saad,A., Weber,E., Mariani,T.J., Starcher,B., Shapiro,S.D. and Cataltepe,S. Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury Am J Respir Crit Care Med (2007) 176, 778-785. PubMed Europe PubMed DOI PMC EPMC
Inagaki,H., Tsuruoka,H., Hornsby,M., Lesley,S.A., Spraggon,G. and Ellman,J.A. Characterization and optimization of selective, nonpeptidic inhibitors of cathepsin S with an unprecedented binding mode J Med Chem (2007) 50, 2693-2699. PubMed Europe PubMed DOI I
Kramer,G., Paul,A., Kreusch,A., Schuler,S., Wiederanders,B. and Schilling,K. Optimized folding and activation of recombinant procathepsin L and S produced in Escherichia coli Protein Expr Purif (2007) 54, 147-156. PubMed Europe PubMed DOI E
Naour,N., Taleb,S., Guerre-Millo,M. and Clement,K. Does cathepsin S play a role in obesity? [Quelle implication pour la cathepsine S dans l'obesite?] Obesite (2007) 2, 260-264. DOI
Soualhine,H., Deghmane,A.E., Sun,J., Mak,K., Talal,A., Av-Gay,Y. and Hmama,Z. Mycobacterium bovis bacillus Calmette-Guerin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages J Immunol (2007) 179, 5137-5145. PubMed Europe PubMed
Taleb,S. and Clement,K. Emerging role of cathepsin S in obesity and its associated diseases Clin Chem Lab Med (2007) 45, 328-332. PubMed Europe PubMed DOI
Wei,J., Pio,B.A., Cai,H., Meduna,S.P., Sun,S., Gu,Y., Jiang,W., Thurmond,R.L., Karlsson,L. and Edwards,J.P. Pyrazole-based cathepsin S inhibitors with improved cellular potency Bioorg Med Chem Lett (2007) 17, 5525-5528. PubMed Europe PubMed DOI I

2006

[YEAR:10-1-2006]Alper,P.B., Liu,H., Chatterjee,A.K., Nguyen,K.T., Tully,D.C., Tumanut,C., Li,J., Harris,J.L., Tuntland,T., Chang,J., Gordon,P., Hollenbeck,T. and Karanewsky,D.S. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl Bioorg Med Chem Lett (10-1-2006) 16, 1486-1490. PubMed Europe PubMed DOI I
[YEAR:18-9-2006]Cheng,X.W., Obata,K., Kuzuya,M., Izawa,H., Nakamura,K., Asai,E., Nagasaka,T., Saka,M., Kimata,T., Noda,A., Nagata,K., Jin,H., Shi,G.P., Iguchi,A., Murohara,T. and Yokota,M. Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure Hypertension (18-9-2006) 48, 979-987. PubMed Europe PubMed DOI
[YEAR:6-3-2006]Choe,Y., Leonetti,F., Greenbaum,D.C., Lecaille,F., Bogyo,M., Bromme,D., Ellman,J.A. and Craik,C.S. Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities J Biol Chem (6-3-2006) 281, 12824-12832. PubMed Europe PubMed DOI P
[YEAR:28-3-2006]Desai,S.N., White,D.M., O'shea,K.M., Brown,M.L., Cywin,C.L., Spero,D.M. and Panzenbeck,M.J. An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity Eur J Pharmacol (28-3-2006) 538, 168-174. PubMed Europe PubMed DOI I
[YEAR:20-3-2006]Flannery,T., McQuaid,S., McGoohan,C., McConnell,R.S., McGregor,G., Mirakhur,M., Hamilton,P., Diamond,J., Cran,G., Walker,B., Scott,C., Martin,L., Ellison,D., Patel,C., Nicholson,C., Mendelow,D., McCormick,D. and Johnston,P.G. Cathepsin S expression: an independent prognostic factor in glioblastoma tumours - a pilot study Int J Cancer (20-3-2006) 119, 854-860. PubMed Europe PubMed DOI
[YEAR:1-2-2006]Grice,C.A., Tays,K., Khatuya,H., Gustin,D.J., Butler,C.R., Wei,J., Sehon,C.A., Sun,S., Gu,Y., Jiang,W., Thurmond,R.L., Karlsson,L. and Edwards,J.P. The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors Bioorg Med Chem Lett (1-2-2006) 16, 2209-2212. PubMed Europe PubMed DOI I
Kaulmann,G., Palm,G.J., Schilling,K., Hilgenfeld,R. and Wiederanders,B. The crystal structure of a Cys25 -> Ala mutant of human procathepsin S elucidates enzyme-prosequence interactions Protein Sci (2006) 15, 2619-2629. PubMed Europe PubMed DOI PMC EPMC S
Link,J.O. and Zipfel,S. Advances in cathepsin S inhibitor design Curr Opin Drug Discov Devel (2006) 9, 471-482. PubMed Europe PubMed T I
Linke,M., Gordon,R.E., Brillard,M., Lecaille,F., Lalmanach,G. and Bromme,D. Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins Biol Chem (2006) 387, 1295-1303. PubMed Europe PubMed DOI P
Park,Y.G., Kim,Y.H., Kang,S.K. and Kim,C.H. cAMP-PKA signaling pathway regulates bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts Int Immunopharmacol (2006) 6, 947-956. PubMed Europe PubMed DOI
[YEAR:19-10-2006]Patterson,A.W., Wood,W.J., Hornsby,M., Lesley,S., Spraggon,G. and Ellman,J.A. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin S using the substrate activity screening method J Med Chem (19-10-2006) 49, 6298-6307. PubMed Europe PubMed DOI I
[YEAR:12-1-2006]Rodgers,K.J., Watkins,D.J., Miller,A.L., Chan,P.Y., Karanam,S., Brissette,W.H., Long,C.J. and Jackson,C.L. Destabilizing role of cathepsin S in murine atherosclerotic plaques Arterioscler Thromb Vasc Biol (12-1-2006) 26, 851-856. PubMed Europe PubMed DOI
Ruckrich,T., Brandenburg,J., Cansier,A., Muller,M., Stevanovic,S., Schilling,K., Wiederanders,B., Beck,A., Melms,A., Reich,M., Driessen,C. and Kalbacher,H. Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain Biol Chem (2006) 387, 1503-1511. PubMed Europe PubMed DOI P
Sugano,E., Tomita,H., Ishiguro,S., Isago,H. and Tamai,M. Nitric oxide-induced accumulation of lipofuscin-like materials is caused by inhibition of cathepsin S Curr Eye Res (2006) 31, 607-616. PubMed Europe PubMed DOI
Sukhova,G.K. and Shi,G.P. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis? Ann N Y Acad Sci (2006) 1085, 161-169. PubMed Europe PubMed DOI
[YEAR:4-1-2006]Taleb,S., Cancello,R., Poitou,C., Rouault,C., Sellam,P., Levy,P., Bouillot,J.L., Coussieu,C., Basdevant,A., Guerre-Millo,M., Lacasa,D. and Clement,K. Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women J Clin Endocrinol Metab (4-1-2006) 91, 1042-1047. PubMed Europe PubMed DOI
[YEAR:6-7-2006]Taleb,S., Cancello,R., Clement,K. and Lacasa,D. Cathepsin S promotes human preadipocyte differentiation: possible involvement of fibronectin degradation Endocrinology (6-7-2006) 147, 4950-4959. PubMed Europe PubMed DOI
[YEAR:27-1-2006]Tully,D.C., Liu,H., Alper,P.B., Chatterjee,A.K., Epple,R., Roberts,M.J., Williams,J.A., Nguyen,K.T., Woodmansee,D.H., Tumanut,C., Li,J., Spraggon,G., Chang,J., Tuntland,T., Harris,J.L. and Karanewsky,D.S. Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3 Bioorg Med Chem Lett (27-1-2006) 16, 1975-1980. PubMed Europe PubMed DOI S I
[YEAR:27-7-2006]Tully,D.C., Liu,H., Chatterjee,A.K., Alper,P.B., Epple,R., Williams,J.A., Roberts,M.J., Woodmansee,D.H., Masick,B.T., Tumanut,C., Li,J., Spraggon,G., Hornsby,M., Chang,J., Tuntland,T., Hollenbeck,T., Gordon,P., Harris,J.L. and Karanewsky,D.S. Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers Bioorg Med Chem Lett (27-7-2006) 16, 5112-5117. PubMed Europe PubMed DOI I
[YEAR:27-7-2006]Tully,D.C., Liu,H., Chatterjee,A.K., Alper,P.B., Williams,J.A., Roberts,M.J., Mutnick,D., Woodmansee,D.H., Hollenbeck,T., Gordon,P., Chang,J., Tuntland,T., Tumanut,C., Li,J., Harris,J.L. and Karanewsky,D.S. Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors Bioorg Med Chem Lett (27-7-2006) 16, 5107-5111. PubMed Europe PubMed DOI I
[YEAR:19-12-2006]Wang,B., Sun,J., Kitamoto,S., Yang,M., Grubb,A., Chapman,H.A., Kalluri,R. and Shi,G.P. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors J Biol Chem (19-12-2006) 281, 6020-6029. PubMed Europe PubMed DOI
[YEAR:1-1-2006]Wang,Y., Baron,R.M., Zhu,G., Joo,M., Christman,J.W., Silverman,E.S., Perrella,M.A., Riese,R.J. and Cernadas,M. PU.1 Regulates cathepsin S expression in professional APCs J Immunol (1-1-2006) 176, 275-283. PubMed Europe PubMed

2005

[YEAR:1-2-2005]Beers,C., Burich,A., Kleijmeer,M.J., Griffith,J.M., Wong,P. and Rudensky,A.Y. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo J Immunol (1-2-2005) 174, 1205-1212. PubMed Europe PubMed
[YEAR:11-8-2005]Boes,M., van der Wel,N., Peperzak,V., Kim,Y.M., Peters,P.J. and Ploegh,H. In vivo control of endosomal architecture by class II-associated invariant chain and cathepsin S Eur J Immunol (11-8-2005) 35, 2552-2562. PubMed Europe PubMed DOI
[YEAR:15-3-2005]Gustin,D.J., Sehon,C.A., Wei,J., Cai,H., Meduna,S.P., Khatuya,H., Sun,S., Gu,Y., Jiang,W., Thurmond,R.L., Karlsson,L. and Edwards,J.P. Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors Bioorg Med Chem Lett (15-3-2005) 15, 1687-1691. PubMed Europe PubMed DOI I
Kitamura,H., Kamon,H., Sawa,S., Park,S.J., Katunuma,N., Ishihara,K., Murakami,M. and Hirano,T. IL-6-STAT3 Controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells Immunity (2005) 23, 491-502. PubMed Europe PubMed DOI
[YEAR:15-11-2005]Liu,H., Tully,D.C., Epple,R., Bursulaya,B., Li,J., Harris,J.L., Williams,J.A., Russo,R., Tumanut,C., Roberts,M.J., Alper,P.B., He,Y. and Karanewsky,D.S. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1 Bioorg Med Chem Lett (15-11-2005) 15, 4979-4984. PubMed Europe PubMed DOI I
[YEAR:28-6-2005]Taleb,S., Lacasa,D., Bastard,J.P., Poitou,C., Cancello,R., Pelloux,V., Viguerie,N., Benis,A., Zucker,J.D., Bouillot,J.L., Coussieu,C., Basdevant,A., Langin,D. and Clement,K. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis FASEB J (28-6-2005) 19, 1540-1542. PubMed Europe PubMed DOI
Thurmond,R.L., Sun,S., Karlsson,L. and Edwards,J.P. Cathepsin S inhibitors as novel immunomodulators Curr Opin Investig Drugs (2005) 6, 473-482. PubMed Europe PubMed I
[YEAR:14-2-2005]Vasiljeva,O., Dolinar,M., Pungercar,J.R., Turk,V. and Turk,B. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans FEBS Lett (14-2-2005) 579, 1285-1290. PubMed Europe PubMed DOI
[YEAR:1-2-2005]Yang,H., Kala,M., Scott,B.G., Goluszko,E., Chapman,H.A. and Christadoss,P. Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis J Immunol (1-2-2005) 174, 1729-1737. PubMed Europe PubMed
Yasuda,Y., Kaleta,J. and Bromme,D. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics Adv Drug Deliv Rev (2005) 57, 973-993. PubMed Europe PubMed DOI T I

2004

[YEAR:11-12-2004]Golden,J.W., Bahe,J.A., Lucas,W.T., Nibert,M.L. and Schiff,L.A. Cathepsin S supports acid-independent infection by some reoviruses J Biol Chem (11-12-2004) 279, 8547-8557. PubMed Europe PubMed DOI
Kirschke,H. Cathepsin S [ISSN:0-12-079610-4] (2004) 2, 1104-1107. V
Liu,W. and Spero,D.M. Cysteine protease cathepsin S as a key step in antigen presentation Drug News Perspect (2004) 17, 357-363. PubMed Europe PubMed DOI
Marquis,R.W. Inhibition of the cysteine protease cathepsin K (EC 3.4.22.38) Annu Rep Med Chem (2004) 39, 79-98. DOI V I
Shen,L., Sigal,L.J., Boes,M. and Rock,K.L. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo Immunity (2004) 21, 155-165. PubMed Europe PubMed DOI
[YEAR:23-9-2004]Thurmond,R.L., Beavers,M.P., Cai,H., Meduna,S.P., Gustin,D.J., Sun,S., Almond,H.J., Karlsson,L. and Edwards,J.P. Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S J Med Chem (23-9-2004) 47, 4799-4801. PubMed Europe PubMed DOI I
[YEAR:17-10-2004]Thurmond,R.L., Sun,S., Sehon,C.A., Baker,S.M., Cai,H., Gu,Y., Jiang,W., Riley,J.P., Williams,K.N., Edwards,J.P. and Karlsson,L. Identification of a potent and selective noncovalent cathepsin S inhibitor J Pharmacol Exp Ther (17-10-2004) 308, 268-276. PubMed Europe PubMed DOI I

2003

Baker,S.M., Karlsson,L. and Thurmond,R.L. Cloning, expression, purification, and activity of dog (Canis familiaris) and monkey (Saimiri boliviensis) cathepsin S Protein Expr Purif (2003) 28, 93-101. PubMed Europe PubMed DOI
[YEAR:20-1-2003]Beers,C., Honey,K., Fink,S., Forbush,K. and Rudensky,A. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages J Exp Med (20-1-2003) 197, 169-179. PubMed Europe PubMed DOI PMC EPMC
Flannery,T., Gibson,D., Mirakhur,M., McQuaid,S., Greenan,C., Trimble,A., Walker,B., McCormick,D. and Johnston,P.G. The clinical significance of cathepsin S expression in human astrocytomas Am J Pathol (2003) 163, 175-182. PubMed Europe PubMed DOI PMC EPMC
Henningsson,F., Wolters,P., Chapman,H.A., Caughey,G.H. and Pejler,G. Mast cell cathepsins C and S control levels of carboxypeptidase A and the chymase, mouse mast cell protease 5 Biol Chem (2003) 384, 1527-1531. PubMed Europe PubMed DOI
[YEAR:26-12-2003]Lindstedt,L., Lee,M., Oorni,K., Bromme,D. and Kovanen,P.T. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells Biochem Biophys Res Commun (26-12-2003) 312, 1019-1024. PubMed Europe PubMed DOI
[YEAR:25-3-2003]Pauly,T.A., Sulea,T., Ammirati,M., Sivaraman,J., Danley,D.E., Griffor,M.C., Kamath,A.V., Wang,I.K., Laird,E.R., Seddon,A.P., Menard,R., Cygler,M. and Rath,V.L. Specificity determinants of human cathepsin S revealed by crystal structures of complexes Biochemistry (25-3-2003) 42, 3203-3213. PubMed Europe PubMed DOI S
[YEAR:21-3-2003]Shi,G.P., Sukhova,G.K., Kuzuya,M., Ye,Q., Du,J., Zhang,Y., Pan,J.H., Lu,M.L., Cheng,X.W., Iguchi,A., Perrey,S., Lee,A.M., Chapman,H.A. and Libby,P. Deficiency of the cysteine protease cathepsin S impairs microvessel growth Circ Res (21-3-2003) 92, 493-500. PubMed Europe PubMed DOI K
Sukhova,G.K., Zhang,Y., Pan,J.H., Wada,Y., Yamamoto,T., Naito,M., Kodama,T., Tsimikas,S., Witztum,J.L., Lu,M.L., Sakara,Y., Chin,M.T., Libby,P. and Shi,G.P. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice J Clin Invest (2003) 111, 897-906. PubMed Europe PubMed DOI PMC EPMC
Wiendl,H., Lautwein,A., Mitsdorffer,M., Krause,S., Erfurth,S., Wienhold,W., Morgalla,M., Weber,E., Overkleeft,H.S., Lochmuller,H., Melms,A., Tolosa,E. and Driessen,C. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies J Neuroimmunol (2003) 138, 132-143. PubMed Europe PubMed DOI

2002

Hou,W.S., Li,W., Keyszer,G., Weber,E., Levy,R., Klein,M.J., Gravallese,E.M., Goldring,S.R. and Bromme,D. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium Arthritis Rheum (2002) 46, 663-674. PubMed Europe PubMed DOI
Pluger,E.B., Boes,M., Alfonso,C., Schroter,C.J., Kalbacher,H., Ploegh,H.L. and Driessen,C. Specific role for cathepsin S in the generation of antigenic peptides in vivo Eur J Immunol (2002) 32, 467-476. PubMed Europe PubMed DOI
Saegusa,K., Ishimaru,N., Yanagi,K., Arakaki,R., Ogawa,K., Saito,I., Katunuma,N. and Hayashi,Y. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity J Clin Invest (2002) 110, 361-369. PubMed Europe PubMed DOI PMC EPMC I
Tobbell,D.A., Middleton,B.J., Raines,S., Needham,M.R., Taylor,I.W., Beveridge,J.Y. and Abbott,W.M. Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens Protein Expr Purif (2002) 24, 242-254. PubMed Europe PubMed DOI E
Turkenburg,J.P., Lamers,M.B., Brzozowski,A.M., Wright,L.M., Hubbard,R.E., Sturt,S.L. and Williams,D.H. Structure of a Cys25->Ser mutant of human cathepsin S Acta Crystallogr D Biol Crystallogr (2002) 58, 451-455. PubMed Europe PubMed DOI S
[YEAR:5-12-2002]Ward,Y.D., Thomson,D.S., Frye,L.L., Cywin,C.L., Morwick,T., Emmanuel,M.J., Zindell,R., McNeil,D., Bekkali,Y., Giradot,M., Hrapchak,M., DeTuri,M., Crane,K., White,D., Pav,S., Wang,Y., Hao,M.H., Grygon,C.A., Labadia,M.E., Freeman,D.M., Davidson,W., Hopkins,J.L., Brown,M.L., Spero,D.M. and Giradot,M. Design and synthesis of dipeptide nitriles as reversible and potent cathepsin S inhibitors J Med Chem (5-12-2002) 45, 5471-5482. PubMed Europe PubMed DOI I

2001

Beck,H., Schwarz,G., Schroter,C.J., Deeg,M., Baier,D., Stevanovic,S., Weber,E., Driessen,C. and Kalbacher,H. Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro Eur J Immunol (2001) 31, 3726-3736. PubMed Europe PubMed DOI
[YEAR:22-6-2001]Honey,K., Duff,M., Beers,C., Brissette,W.H., Elliott,E.A., Peters,C., Maric,M., Cresswell,P. and Rudensky,A. Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes J Biol Chem (22-6-2001) 276, 22573-22578. PubMed Europe PubMed DOI K
Mason,C.S., Lamers,M.B., Henderson,I.M., Monk,T. and Williams,D.H. Baculoviral expression and characterization of rodent cathepsin S Protein Expr Purif (2001) 23, 45-54. PubMed Europe PubMed DOI
[YEAR:16-3-2001]Quraishi,O. and Storer,A.C. Identification of internal autoproteolytic cleavage sites within the prosegments of recombinant procathepsin B and procathepsin S. Contribution of a plausible unimolecular autoproteolytic event for the processing of zymogens belonging to the papain family J Biol Chem (16-3-2001) 276, 8118-8124. PubMed Europe PubMed DOI
Riese,R.J., Shi,G.P., Villadangos,J., Stetson,D., Driessen,C., Lennon-Dumenil,A.M., Chu,C.L., Naumov,Y., Behar,S.M., Ploegh,H., Locksley,R. and Chapman,H.A. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S Immunity (2001) 15, 909-919. PubMed Europe PubMed DOI K
Wasselius,J., Hakansson,K., Johansson,K., Abrahamson,M. and Ehinger,B. Identification and localization of retinal cystatin C Invest Ophthalmol Vis Sci (2001) 42, 1901-1906. PubMed Europe PubMed

2000

Guay,J., Falgueyret,J.P., Ducret,A., Percival,M.D. and Mancini,J.A. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides Eur J Biochem (2000) 267, 6311-6318. PubMed Europe PubMed DOI
[YEAR:10-3-2000]Guo,Y.L., Kurz,U., Schultz,J.E., Lim,C.C., Wiederanders,B. and Schilling,K. The alpha1/2 helical backbone of the prodomains defines the intrinsic inhibitory specificity in the cathepsin L-like cysteine protease subfamily FEBS Lett (10-3-2000) 469, 203-207. PubMed Europe PubMed DOI
Kreusch,S., Fehn,M., Maubach,G., Nissler,K., Rommerskirch,W., Schilling,K., Weber,E., Wenz,I. and Wiederanders,B. An evolutionarily conserved tripartite tryptophan motif stabilizes the prodomains of cathepsin L-like cysteine proteases Eur J Biochem (2000) 267, 2965-2972. PubMed Europe PubMed DOI
[YEAR:15-7-2000]Krupa,J.C. and Mort,J.S. Optimization of detergents for the assay of cathepsins B, L, S, and K Anal Biochem (15-7-2000) 283, 99-103. PubMed Europe PubMed DOI A
[YEAR:28-8-2000]Walker,B., Lynas,J.F., Meighan,M.A. and Bromme,D. Evaluation of dipeptide alpha-keto-beta-aldehydes as new inhibitors of cathepsin S Biochem Biophys Res Commun (28-8-2000) 275, 401-405. PubMed Europe PubMed DOI I

1999

[YEAR:15-11-1999]Driessen,C., Bryant,R.A., Lennon-Dumenil,A.M., Villadangos,J.A., Bryant,P.W., Shi,G.P., Chapman,H.A. and Ploegh,H.L. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells J Cell Biol (15-11-1999) 147, 775-790. PubMed Europe PubMed DOI PMC EPMC
Liuzzo,J.P., Petanceska,S.S. and Devi,L.A. Neurotrophic factors regulate cathepsin S in macrophages and microglia: a role in the degradation of myelin basic protein and amyloid beta peptide Mol Med (1999) 5, 334-343. PubMed Europe PubMed PMC EPMC
Liuzzo,J.P., Petanceska,S.S., Moscatelli,D. and Devi,L.A. Inflammatory mediators regulate cathepsin S in macrophages and microglia: a role in attenuating heparan sulfate interactions Mol Med (1999) 5, 320-333. PubMed Europe PubMed PMC EPMC
Nissler,K., Strubel,W., Kreusch,S., Rommerskirch,W., Weber,E. and Wiederanders,B. The half-life of human procathepsin S Eur J Biochem (1999) 263, 717-725. PubMed Europe PubMed DOI E
Werle,B., Staib,A., Julke,B., Ebert,W., Zladoidsky,P., Sekirnik,A., Kos,J. and Spiess,E. Fluorometric microassays for the determination of cathepsin L and cathepsin S activities in tissue extracts Biol Chem (1999) 380, 1109-1116. PubMed Europe PubMed DOI A

1998

McGrath,M.E., Palmer,J.T., Bromme,D. and Somoza,J.R. Crystal structure of human cathepsin S Protein Sci (1998) 7, 1294-1302. PubMed Europe PubMed DOI PMC EPMC S I
Rakoczy,P.E., Lai,M.C., Baines,M.G., Spilsbury,K. and Constable,I.J. Expression of cathepsin S antisense transcripts by adenovirus in retinal pigment epithelial cells Invest Ophthalmol Vis Sci (1998) 39, 2095-2104. PubMed Europe PubMed K
[YEAR:1-8-1998]Sukhova,G.K., Shi,G.P., Simon,D.I., Chapman,H.A. and Libby,P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells J Clin Invest (1-8-1998) 102, 576-583. PubMed Europe PubMed DOI PMC EPMC

1996

Bromme,D. and McGrath,M.E. High level expression and crystallization of recombinant human cathepsin S Protein Sci (1996) 5, 789-791. PubMed Europe PubMed DOI PMC EPMC E
Kopitar,G., Dolinar,M., Strukelj,B., Pungercar,J. and Turk,V. Folding and activation of human procathepsin S from inclusion bodies produced in Escherichia coli Eur J Biochem (1996) 236, 558-562. PubMed Europe PubMed E

1994

Bromme,D., Bonneau,P.R., Lachance,P. and Storer,A.C. Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity J Biol Chem (1994) 269, 30238-30242. PubMed Europe PubMed
Gour-Salin,B.J., Lachance,P., Bonneau,P.R., Storer,A.C., Kirschke,H. and Bromme,D. E-64 analogs as inhibitors of cathepsin L and cathepsin S: importance of the S2-P2 interactions for potency and selectivity Bioorg Chem (1994) 22, 227-241. I
Kirschke,H. and Wiederanders,B. Cathepsin S and related lysosomal endopeptidases Methods Enzymol (1994) 244, 500-511. PubMed Europe PubMed DOI V
Rakoczy,P.E., Mann,K., Cavaney,D.M., Robertson,T., Papadimitreou,J. and Constable,I.J. Detection and possible functions of a cysteine protease involved in digestion of rod outer segments by retinal pigment epithelial cells Invest Ophthalmol Vis Sci (1994) 35, 4100-4108. PubMed Europe PubMed K
[YEAR:14-2-1994]Turk,B., Colic,A., Stoka,V. and Turk,V. Kinetics of inhibition of bovine cathepsin S by bovine stefin B FEBS Lett (14-2-1994) 339, 155-159. PubMed Europe PubMed DOI

1993

Bromme,D., Bonneau,P.R., Lachance,P., Wiederanders,B., Kirschke,H., Peters,C., Thomas,D.Y., Storer,A.C. and Vernet,T. Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme J Biol Chem (1993) 268, 4832-4838. PubMed Europe PubMed
Menard,R., Carmona,E., Plouffe,C., Bromme,D., Konishi,Y., Lefebvre,J. and Storer,A.C. The specificity of the S1' subsite of cysteine proteases FEBS Lett (1993) 328, 107-110. PubMed Europe PubMed DOI
Shaw,E., Mohanty,S., Colic,A., Stoka,V. and Turk,V. The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones. Comparison with the inhibition of cathepsin L and calpain FEBS Lett (1993) 334, 340-342. PubMed Europe PubMed DOI I

1992

Dolenc,I., Ritonja,A., Colic,A., Podobnik,M., Ogrinc,T. and Turk,V. Bovine cathepsins S and L: isolation and amino acid sequences Biol Chem Hoppe Seyler (1992) 373, 407-412. PubMed Europe PubMed
Shi,G.P., Munger,J.S., Meara,J.P., Rich,D.H. and Chapman,H.A. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease J Biol Chem (1992) 267, 7258-7262. PubMed Europe PubMed
Wiederanders,B., Bromme,D., Kirschke,H., von Figura,K., Schmidt,B. and Peters,C. Phylogenetic conservation of cysteine proteinases. Cloning and expression of a cDNA coding for human cathepsin S J Biol Chem (1992) 267, 13708-13713. PubMed Europe PubMed

1991

Bromme,D., Rinne,R. and Kirschke,H. Tight-binding inhibition of cathepsin S by cystatins Biomed Biochim Acta (1991) 50, 631-635. PubMed Europe PubMed
Ritonja,A., Colic,A., Dolenc,I., Ogrinc,T., Podobnik,M. and Turk,V. The complete amino acid sequence of bovine cathepsin S and a partial sequence of bovine cathepsin L FEBS Lett (1991) 283, 329-331. PubMed Europe PubMed DOI
Wiederanders,B., Broemme,D., Kirschke,H., Kalkkinen,N., Rinne,A., Paquette,T. and Toothman,P. Primary structure of bovine cathepsin S. Comparison to cathepsins L, H, B and papain FEBS Lett (1991) 286, 189-192. PubMed Europe PubMed DOI

1989

[YEAR:1-12-1989]Bromme,D., Steinert,A., Friebe,S., Fittkau,S., Wiederanders,B. and Kirschke,H. The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B Biochem J (1-12-1989) 264, 475-481. PubMed Europe PubMed PMC EPMC
[YEAR:1-12-1989]Kirschke,H., Wiederanders,B., Bromme,D. and Rinne,A. Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins Biochem J (1-12-1989) 264, 467-473. PubMed Europe PubMed PMC EPMC

1986

Kirschke,H., Schmidt,I. and Wiederanders,B. Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15) Biochem J (1986) 240, 455-459. PubMed Europe PubMed PMC EPMC

1975

Turnsek,T., Kregar,I. and Lebez,D. Acid sulphydryl protease from calf lymph nodes Biochim Biophys Acta (1975) 403, 514-520. PubMed Europe PubMed